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(ii) 
SUMMARY 
In this study, the structure and function of gonadotropin-releasing 
hormone (GnRH) in different vertebrate species, in the classes Aves, 
Reptilia and Pisces was investigated. Acetic acid extracts were 
subjected to gel filtration chromatography and semipreparative high 
performance liquid chromatography (HPLC) to partially purify the GnRHs. 
The GnRH immunoreactivity was then characterized by analytical HPLC, and 
by assaying HPLC fractions by 
antisera generated against mammalian 
radioimmunoassay with 
GnRH, Gln8-GnRH and 
region-specific 
Trp7,Leu8-GnRH 
and assessing luteinizing hormone (LH)-releasing activity of fractions in 
a chicken dispersed anterior pituitary cell bioassay. 
Five GnRH molecular forms have thusfar been structurally characterized in 
vertebrate brain. In mammals a GnRH with the structure 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 has been demonstrated in the 
hypothalamus (Matsuo et al., 1971; Burgus et al., 1972). Gln8-GnRH and 
His 5 ,Trp 7 ,Tyr8-GnRH were present in chicken hypothalamus (King and 
Millar, 1982a, 1982c; Miyamoto et al., 1983, 1984), Trp 7 ,Leu 8-GnRH in 
salmon brain (Sherwood et al., 1983) and Tyr3 ,Leu5,Glu 6 ,Trp 7 ,Lys 8-GnRH in 
lamprey brain (Sherwood et al., 1986). 
In ostrich (Struthio camelus) hypothalamus two GnRHs with identical 
properties to Gln8-GnRH and His5,Trp 7 ,Tyr8-GnRH have been demonstrated, 
as well as four other LR-releasing factors with different chromatographic 
and immunological properties to any of the known naturally-occurring 
GnRHs. Since Gln8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH were also present in 
chicken hypothalamus it appears likely that these two GnRHs occur in all 
birds. 
( iii ) 
In alligator (Alli~ator mississippiensis) brain only two GnRHs were 
detected. These forms co-eluted with Gln8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH 
in two HPLC systems. They cross-reacted similarly to the two synthetic 
peptides with antisera directed against mammalian GnRH and Gln8-GnRH and 
released LH from chicken dispersed anterior pituitary cells in a similar 
manner to the synthetic peptides. The Archosaurs (alligators and 
crocodiles) are believed to be closely related to birds and therefore it 
seems likely that they should have identical GnRHs. In skink (Calcides 
ocellatus tiligugu) brain one GnRH, which co-eluted with 
His5,Trp 7 ,Tyr8-GnRH, was demonstrated. Two other lizards (Cordylis ni~ra 
and Pordarcis s. sicula) have been studied (Powell et al., 1985; R.C. 
Powell, G. Ciarcia, V. Lance, R.P. Millar and J.A. King, submitted). In 
c. nigra four immunoreactive GnRHs were detected, two of which co-eluted 
released chicken LH similarly to, Trp 7 ,Leu8-GnRH and with, and 
His 5 ,Trp 7 ,Tyr8-GnRH. In P. s. sicula a GnRH molecular form similar to 
Trp 7 ,Leu8-GnRH occurred as well as two novel GnRHs. It thus appears that 
Gln8-GnRH does not occur in lower reptiles, but His5,Trp7,Tyr8-GnRH 
and/or Trp 7 ,Leu8-GnRH do. His5,Trp 7 ,Tyr8-GnRH appears to he a widespread 
GnRH, occurring in vertebrates as diverse as birds and elasmobranch fish. 
In dogfish (Poroderma africanum) brain seven factors, which stimulated 
release of LH from chicken dispersed anterior pituitary cells, were 
separated on analytical HPLC. 
characterized as Trp 7 ,Leu8-GnRH 
Two of these factors 
and His 5 ,Trp 7 ,Tyr8-GnRH. 
were partially 
Three of the 
other forms cross-reacted with GnRH antisera, but appear to be novel 
GnRHs. In teleost 
Trp 7 ,Leu8-GnRH and 
(Coris j ulis) brain 
were 
two GnRHs similar to 
present. 
therefore appear to occur in both fish species studied. 
These two GnRHs 
Trp 7 ,Leu8-GnRH 
(iv) 
is widespread amongst teleost fish (Jackson and Pan, 1983; Sherwood et 
al., 1983; Breton et al., 1984; Sherwood et al., 1984; King and Millar, 
1985). 
From these data it seems evident that the mammalian GnRH molecular form 
occurs only in mammals and amphibians, Gln8-GnRH in birds and higher 
reptiles, and Trp 7 ,Leu8-GnRH in ~nathostomes. His 5 ,Trp 7 ,Tyr8-GnRH 
appears to he present in numerous different vertebrates. 
Tyr3 ,Leu5 ,G1u 6 ,Trp 7 ,Lys8-GnRH has thus far only been detected in lamprey 
brain. A number of novel GnRHs, whose structures have not been 
elucidated are present. 
(v) 
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1.0 INTRODUCTION 
2 
In mammals, secretion of anterior pituitary hormones is controlled by 
factors released from hypothalamus into the portal blood. 
Gonadotropin-releasing hormone (GnRH) is a decapeptide (Fig. 1) which 
stimulates release of luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH) from the anterior pituitary (Schally, 1978). This GnRH was 
initially isolated from porcine and ovine hypothalamus, and subsequently 
considerable diversity of GnRH structure has been demonstrated in other 
vertebrate species (King and Millar, 1982a, 1982b; Miyamoto et al., 1983, 
1984; Sherwood et al., 1983, 1986) (Fig. 1). 
The portal vascular system linking the hypothalamus and anterior 
pituitary has also been described in birds (Green, 1951), amphibians and 
reptiles (Ball, 1981). In fish there appears to be considerable 
anatomical variation. In teleosts the hypothalamus interdigitates with 
the anterior pituitary and thus there may be direct neurogenic control of 
the pituitary by the hypothalamus (Ball, 1981). Elasmobranchs have a 
well-developed median eminence, however, there is no vascular or nervous 
relationship with the ventral lobe of the pars distalis, where 
gonadotropin is released (Holmes and Ball, 1974; Dodd, 1975). Thus 
control of gonadotropin release may occur via the systemic circulation. 
In cyclostomes there is either no anatomic relationship of a vascular or 
neural type, or an inefficient one, for transfer of hypothalamic factors 
to the anterior pituitary (Ball, 1981). Hypothalamic regulatory factors 
may reach the anterior pituitary either via the systemic circulation or 
across connective tissue (Nozaki et al., 1984b; Dodd, 1975). 
Neurohormones could diffuse through the connective tissue into underlying 
blood vessels which supply the pars distalis (Belenky et al., 1979). 
MAMMALIAN GnRH 
porcine and ovine 
AVIAN GnRH 
chicken I 
chicken II 
AMPHIBIAN GnRH 
frog 
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lamprey 
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Fig. 1. Known vertebrate GnRHs. Only amino acids which differ from the 
mammalian decapeptide are indicated. 
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1.1 PHYLOGENETIC DISTRIBUTION OF GnRH IN VERTEBRATE BRAIN 
Mammals 
In 1947 Green and Harris postulated that a factor which controls release 
of LH and FSH from the anterior pituitary existed. This factor was, 
however, only discovered 25 years later by two groups of workers. 
Porcine (Matsuo et al., 1971) and ovine (Burgus et al., 1972) 
hypothalamic GnRH was isolated and sequenced (Fig. 1), and the structure 
was found to he the same in both mammalian species. The GnRH molecule is 
a decapeptide with a pyro-glutamic acid on the N-terminus and glycine 
amide on the C-terminus. This GnRH is thought to occur in all mammals, 
although in only two species has GnRH been thoroughly investigated. A 
second, smaller immunoreactive peak was apparent in ovine hypothalamus 
when chromatographed on CM32 carboxymethyl cellulose cation exchange 
chromatography (King and Millar, 1981). This GnRH molecular form has not 
been characterized, but was less positively charged. A number of studies 
have indicated that GnRH also occurs in extrahypothalamic brain, in 
particular olfactory bulb (Dluzen et al., 1981; Witkin ~ al., 1982; 
Dluzen and Ramirez, 1983; Ibata et al., 1983; Witkin and Silverman, 1983) 
and ovine pineal gland (King and Millar, 1981; Millar et al., 1981; 
Piekut and Knigge, 1981). The ovine pineal gland had a GnRH molecular 
form with identical properties to the hypothalamic GnRH. A second form 
was structurally different from the hypothalamic peptide (King and 
Millar, 1981). This GnRH was less positively charged and eluted earlier 
on cation exchange chromatography. The GnRH in the pineal gland may be 
involved in regulating the process of protein and/or peptide secretion 
5 
(Haldar-Misra and Pevet, 1983). The GnRH in the olfactory bulbs may 
mediate the response to external chemical cues during social encounters 
(Dluzen et al., 1981; Dluzen and Ramirez, 1983). 
Birds 
An early chromatographic and immunological study suggested that mammalian 
and avian GnRH were the same (Jeffcoate et al., 1974). Studies on 
chicken (Gallus domesticus), pigeon (Columbia livia) and quail (Coturnix 
coturnix japonica) hypothalamic GnRHs indicated that avian GnRH differed 
from the mammalian peptide, being less positively charged (Jackson, 1971; 
King and Millar, 1979a, 1980; Hattori et al., 1980). The GnRH in chicken 
and pigeon hypothalamus cross-reacted poorly with middle-directed 
antisera to mammalian GnRH, but had high quantitation with N- and 
C-terminus-directed antisera. Additional data showed that the chicken 
hypothalamic GnRH differs from the mammalian peptide at Arg8 (King and 
Millar, 1982h). Amino acid analysis and partial sequence analysis of 
purified chicken hypothalamic GnRH demonstrated that glutamine replaced 
arginine in position 8 (King and Millar, 1982a, 1982c). This was 
confirmed by Miyamoto et al. (1983). A second form of chicken 
hypothalamic GnRH has been characterized as His 5 ,Trp 7 ,Tyr8-GnRH (Miyamoto 
et al., 1984). Extrahypothalamic brain GnRH has been demonstrated in the 
chicken (King and Millar, 1980; Jo.zsa and Mess, 1982; Knight et al., 
1983) and pigeon (King and Millar, 1980; Weindl et al., 1982). 
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Reptiles 
Immunoreactive GnRH in hypothalamic extracts of lizard (Mabuya capensis) 
and tortoise (Chersine angulata) were immunologically different from 
mammalian GnRH and 
chromatography) (King 
mammalian GnRH in the 
less positively 
and Millar, 1979b, 
vicinity of Leu 7 • 
charged 
1980), 
A recent 
(cation exchange 
differing from the 
study investigated 
lizard (Cordylis nigra) brain GnRH, using high performance liquid 
chromatography (HPLC) and radioimmunoassay with region-specific antisera 
(Powell et al., 1985). A GnRH molecular form with identical properties 
to Trp7,Leu8-GnRH was identified. This peptide had LH-releasing activity 
similar to synthetic Trp 7 ,Leu8-GnRH. In addition, three structurally 
related GnRH molecular forms were detected, one 
elution properties and LR-releasing activity to 
having similar HPLC 
His 5 ,Trp 7 ,Tyr8-GnRH 
(Powell et al., 1985). A preliminary study on alligator (Alligator 
mississippiensis) brain GnRH using a N- and C- terminal-directed 
antiserum and a C- terminal antiserum, demonstrated that the GnRH differs 
from the mammalian peptide in at least the 8 position (Lance, 1985; Lance 
et al., 1985). Extrahypothalamic brain GnRH has been described in the 
tortoise (King and Millar, 1980), but GnRH in different brain regions of 
reptile brain has thusfar not been studied. GnRH appears to have a role 
in the reproductive behaviour of certain reptiles. In the lizard, Anolis 
carolinensis, GnRH increased female sexual receptivity and when female 
iguanas (Iguana iguana) were treated with a Gln8-GnRH analogue, male 
sexual behaviour was stimulated (Alderete et al., 1982; Phillips et al., 
1985). 
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Amphibians 
Immunoreactive GnRH is present in the hypothalamus of frogs (Rana 
pipiens, ~ catesbeiana) (Alpert et al., 1976; Eiden et al., 1982), 
clawed toad (Xenopus laevis) (Deery, 1974; King and Millar, 1979a, 1979b, 
1980) and toad (Bufo gariepensis) (King and Millar, 1980). This GnRH had 
identical chromatographic and immunoreactive properties to mammalian 
GnRH. Seasonal variation of hypothalamic GnRH has been demonstrated in 
X. laevis (King and Millar, 1979b), Bufo japonicus (Jokura and Urano, 
1985; Urano et al., 1985), and in the newt (Taricha granulosa) (Zoeller 
and Moore, 1985), corresponding with seasonal reproductive activity. 
In frog (R. catesbeiana) brain a single GnRH molecular form with 
identical amino acid composition to the mammalian hormone has been 
isolated (Rivier et al., 1981). However, in X. laevis brain two forms of 
GnRH have been identified, having identical immunological and 
chromatographic properties to mammalian GnRH and His
5
,Trp 7 ,Tyr8-GnRH 
(King and Millar, 1986). A number of studies have demonstrated GnRH in 
bullfrog (R. catesbeiana) sympathetic ganglion (Jan et al., 1979; Eiden 
and Eskay, 1980; Branton et al., 1982; Eiden et al., 1982). This GnRH 
is structurally different from mammalian GnRH (Eiden and Eskay, 1980; 
Eiden et al., 1982) and seems to be a transmitter for the late slow 
excitatory postsynaptic potential (Jan et al.,1979, 1980). Branton et al 
(1982) have shown that ganglionic-like GnRH occurs in brain extracts of 
metamorphic and mature adults. In the sympathetic ganglia a GnRH 
molecular form with identical properties to Trp7,Leu8-GnRH was present, 
and is thought to have a neurotransmitter function (Jones et al., 1984). 
8 
Fish 
Numerous immunological studies have demonstrated GnRH in osteichthyes 
brain (see Crim and Vigna, 1983). Tilapia (Sarotherodon mossambicus) 
brain GnRH differed from mammalian GnRH in the vicinity of Leu 7 (King and 
Millar, 1979a, 1980) and was less positively charged, possibly having no 
8 Arg. A GnRH in salmon (Oncorhynchus keta) brain was purified and 
sequenced and had the structure Trp7,Leu8-GnRH (Sherwood et al., 1983). 
Additional GnRH molecular forms were also present in salmon brain 
(Sherwood!!_ al., 1983). Multiple forms of GnRH also occurred in hake 
(Merluccius capensis) pituitary gland, and in the brain of tilapia 
(Tilapia sparrmanii), codfish (Gadus morhua morhua), milkfish (Chanos 
chanos), trout (Salmo gairdneri) and mullet (Mugil cephalus) (Barnett et 
al., 1982; Jackson and Pan, 1983; Sherwood!!_ al., 1984; King and Millar, 
1985). The nature of the molecular variants of GnRH has not been 
determined, however, it appears that most teleosts have a GnRH molecular 
form with similar properties to Trp 7 ,Leu8-GnRH (Jackson and Pan, 1983; 
Breton et al., 1984; Sherwood!!_ al., 1984; King and Millar, 1985). 
In chondrichthyes, immunoreactive GnRH has been detected in dogfish 
(Poroderma africanum and Squalus acanthias) hypothalamus (Jackson, 1980; 
King and Millar 1980) and ratfish (Hydrolasus collie!) hypothalamus 
(Jackson, 1980). S. acanthias brain extract has been chromatographed on 
reverse phase HPLC (Sherwood and Sower, 1985). Two immunoreactive GnRHs 
(antiserum R-42) occurred, neither co-eluting with mammalian GnRH or 
Other elasmobranch fish (Scyliorhinus canicula and 
Triakis scyllia) had no detectable immunoreactive GnRH (Deery, 1974; 
9 
Nozaki and Kobayashi, 1979). More recently, Nozaki et al. (1984a) 
detected GnRH in~ scyllia brain by immunohistochemistry. The structure 
of elasmohranch GnRH has not been elucidated. 
In agnathans, both lamprey and hagfish GnRHs have been studied. The 
lampreys (Entosphenus tridentata, Lampetra richardsoni, E. japonica and 
Petromyzon marinus) exhihited immunoreactivity in brain preparations 
(Crim et al., 1979a, 1979b; Nozaki and Kobayashi, 1979; Nozaki et al., 
1984a; Sherwood and Sower, 1985). Immunoreactive GnRH occurred in the 
hagfish Heptatretus hexatrema (King and Millar, 1980) and Eptatretus 
stout! (Jackson, 1980), whereas E. burger! brain had no detectable 
immunoreactive GnRH (Nozaki and Kobayashi, 1979; Nozaki et al., 1984a). 
Contrary to Jackson's report of immunoreactivity GnRH in E. stout!, 
Sherwood and Sower (1985) did not detect immunoreactive GnRH in E. stout! 
brain. The immunoreactive GnRH in lamprey (P. marinus) brain has been 
chromatographed on reverse phase HPLC and two peaks were detected 
(Sherwood and Sower, 1985). The major peak eluted in the same position 
as mammalian GnRH, but sequence analysis of pu~ified material 
characterized it as Tyr3,Leu 5 ,G1u6,Trp 7 ,Lys8-GnRH (Sherwood et al., 
1986). Amino acid analysis of the second GnRH form in lamprey has been 
performed and a number of novel amino acids occurred (Sherwood~ al., 
1986). 
Extrahypothalamic brain GnRH has been detected in tilapia (S. 
mossamhicus), dogfish (P. africanum) (King and Millar, 1980) and goldfish 
(Carassius auratus) (Stell~ al., 1984) brain. In a number of teleosts 
immunoreactive GnRH seem to occur in the olfactory bulb with processes of 
the GnRH neurons projecting to the retina (Milnz et al., 1982). 
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1.2 GnRH IN OTHER TISSUES 
GnRH has been described in a number of tissues outside the brain and 
these GnRH-like molecules appear to have specific functions. Human 
placental GnRH seems to be indistinguishable from the mammalian 
hypothalamic peptide (Siler-Khodr and Khodr, 1978, 1979; Khodr and 
Siler-Khodr, 1980; Tan and Rousseau, 1982). The GnRH is released by 
placental tissue in vitro (Siler-Khodr and Khodr, 1979; Khodr and 
Siler-Khodr, 1980), and the content in the placenta varies with the 
stages of gestation (Siler-Khodr and Khodr, 1978). A GnRH-like factor 
with immunological and biological activity also occurred in rabbit fetal 
placenta (Nowak et al., 1984) and rat placenta (DePalatis et al., 1980). 
Receptors for GnRH have been described in human placenta (Currie et al., 
1981; Belisle et al., 1984). Placental cell cultures incubated with GnRH 
have stimulated production of hCG, thus suggesting a role for GnRH in 
human placenta (Belisle et al., 1984). 
GnRH in the Leydig cells and seminiferous tubules of rat testes has been 
detected by immunohistochemistry (Paull et al., 1981; Turkelson et al., 
1983). Dutlow and Millar (1981) showed that testicular immunoreactive 
GnRH differs from the hypothalamic peptide. Two factors with GnRH 
receptor-binding properties, which were chemically distinct from the 
native peptide appear to be present in rat testis (Bhasin et al., 1983). 
The two factors had molecular weights of 68 000 and 6 000. GnRH 
receptors were present on the Leydig cells, but not on cells in the 
seminiferous tubules (Bourne!.!_ al., 1980; Clayton!.!_ al., 1980; Sharpe 
and Fraser, 1980; Millar et al., 1982; see Sharpe, 1982). It has been 
speculated that a GnRH-like factor is secreted from Sertoli cells in the 
testes and that this factor 
(Sharpe, 1982). A small 
has an 
peptide 
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inhibitory effect on Leydig cells 
(smaller than 3 500 daltons) found in 
rat follicular fluid stimulated the pituitary to release LH and FSH in 
vitro and in vivo. This GnRH-like peptide eluted differently to 
mammalian GnRH in HPLC and did not cross-react with two antisera 
generated against mammalian GnRH (Ying et al., 1981). This peptide is 
thought to he secreted from the granulosa cells. GnRH receptors have 
been demonstrated on purified granulosa cells (Jones et al., 1980) and on 
luteal cells (Clayton et al., 1979). The GnRH in the ovary affected 
granulosa and luteal cell function (see Sharpe, 1982). 
GnRH-like immunoreactivity in pancreatic islets of the rat co-eluted with 
synthetic and hypothalamic GnRH in cation exchange chromatography and was 
immunologically identical (Seppala et al., 1979). Human pancreatic 
islets also had GnRH immunoreactivity (Wahlstrom and Seppala, 1979; 
Seppala and Wahlstrom, 1980). The function of this GnRH-like molecule 
was not apparent. Immunoreactive GnRH appears to be present in human and 
bovine milk (Baram et al., 1977; Sarda and Nair, 1981; Hazum, 1983). 
This GnRH had similar properties to synthetic mammalian GnRH (Sarda et 
al., 1981). GnRH immunoreactivity occurred in frog (R. catesbeiana) and 
lizard (C. nigra) adrenal gland (Eiden et al., 1982; Powell et al., 
1985), frog (R. catesbeiana and Bufo marinus) and fish (carp, goldfish 
and trout) retina (Eiden et al., 1982; Stell et al., 1984), lizard (C. 
nigra) spinal cord (Powell et al., 1985), human seminal plasma (Chan and 
Tang, 1983), and eel (Anguilla anguilla) and dogfish (P. africanum) 
systemic blood (King and Millar, 1980; Dufour et al., 1982), the 
functions of these factors being unknown. GnRH receptors appear to be 
present in rat adrenal gland (Eidne et al., 1985a) and human mammary 
carcinoma tissue (Eidne et al., 1985b; Miller et al., 1985). 
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1.3 GnRH-LIKE PEPTIDES IN INVERTEBRATES AND OTHER LOWER ORGANISMS 
The protochordate Ciona intestinalis had GnRH-like immunoreactivity in 
its nervous system (Georges and Dubois, 1980). The hepatopancreas of the 
grass shrimp (Penaeus monodon) appears to have immunoreactive and 
biologically active GnRH. No GnRH was detected in other tissues (Wan et 
al., 1984). No GnRH-like activity was detected in the neural ganglia of 
the snail Helix sp. (King and Millar, unpublished). Yeast 0<.. -mating 
factor has extensive sequence homology with GnRH and it bound to rat 
pituitary GnRH receptors and stimulated release of LH from cultured 
pituitary cells (Loumaye et al., 1982) 
1.4 BIOLOGICAL ACTIVITY OF VERTEBRATE GnRHs 
Mammals 
Synthetic mammalian GnRH has heen shown to stimulate release of LH from 
pituitary cells of numerous mammalian species and this suggests that the 
structure of GnRH is conserved in mammals. Gln8-GnRH had 1-5% of the 
LH-releasing activity of the mammalian peptide in rat pituitary cells in 
vitro (Hasegawa et al., 1984; Miyamoto et al., 1984) and in vivo (Sandow 
et al., 1978) and in sheep pituitary cells in vitro (Millar and King, 
1983). Trp 7 ,Leu 8-GnRH had 5% of the LH-releasing activity of mammalian 
GnRH (Sherwood et al., 1983) and His 5 ,Trp7,Tyr8-GnRH 32% (Miyamoto et 
al., 1984) in rat pituitary cells. Tyr 3 ,Leu5,G1u6 ,Trp 7 ,Lys8-GnRH, which 
has recently been isolated from lamprey brain, has not been tested for 
biological activity in the mammalian system. It appears that the 
mammalian GnRH receptor is highly specific in regard to GnRH structure. 
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Birds 
The five naturally-occurring GnRHs have been used to stimulate release of 
LH from chicken dispersed anterior pituitary cells. Mammalian GnRH and 
Gln8-GnRH were equipotent, with an Eo 50 of 3 x 10-lO M (Millar and King, 
1983; Johnson et al., 1984a). Trp 7 ,Leu8-GnRH was 2.5 times more potent 
than mammalian GnRH (Millar and King, 1984) and His 5 ,Trp 7 ,Tyr8-GnRH 5-6 
times more potent (Millar and King, 1984; Chou et al., 1985). 
Tyr3,Leu5,Glu6,Trp 7 ,Lys8-GnRH had 0.001% of the LH-releasing activity of 
mammalian GnRH (J.A. King, R.C. deL. Milton and R.P. Millar, 
unpublished). Mammalian GnRH and Gln8~GnRH were also equipotent in vivo 
in chickens (Johnson et al., 1984b; Sterling and Sharp, 1984) and in 
quails (Chan et al., 1983; Hattori et al., 1985). Therefore, it is 
thought that the GnRH receptor in birds is more promiscuous than the 
mammalian receptor. 
Reptiles 
Very few studies have been performed in reptiles with regard to 
biological activity of the naturally-occur.ring GnRHs. Mammalian GnRH 
appears to be inactive in various turtles (Licht et al., 1984), but it 
was slightly active in stimulating a rise of LH in the turtles Chrysemys 
picta (Callard and Lance, 1977) and C. mydas (Licht, 1980). 
was inactive in a snake (Naja naja) and a turtle (Sternotherus odoratus) 
(Licht~ al., 1984). 
14 
Amphibians 
Numerous studies have shown that synthetic mammalian GnRH stimulates 
gonadotropin secretion in frogs (Thornton and Geschwind, 1974; Daniels 
and Licht, 1980; Mccreery et al., 1982; Licht et al., 1984; Porter and 
Licht 1984). Gln8-GnRH stimulated gonadotropin release similarly to 
mammalian GnRH in the frog R. catesbeiana (Licht et al., 1984). 
Fish 
Synthetic mammalian GnRH increased plasma gonadotropin concentration in 
vivo in a number of teleosts (Peter and Crim, 1979; reviewed by Peter, 
1983). Mammalian GnRH also increased gonadotropin release from rainbow 
trout (S. gairdneri) pituitary gland and goldfish (C. auratus) pituitary 
cells in vitro (Crim and Evans, 1980; Crim~ al., 1981; MacKenzie et 
al., 1984). Trp 7 ,Leu8-GnRH stimulated gonadotropin in the coho salmon 
(Oncorhynchus kisutch) (van der Kraak et al., 1983) and in the goldfish 
1984). Mammalian GnRH, Trp 7 ,Leu8-GnRH (C. auratus) (MacKenzie et al., 
and Gln8-GnRH were equipotent in increasing serum gonadotropin in the 
goldfish (Peter et al., 1985). The activities of His5,Trp 7 ,Tyr8-GnRH and 
Tyr3,Leu5,Glu6,Trp7,Lys8-GnRH in teleosts are not known. 
In the dogfish (S. canicula), an elasmobranch fish, GnRH stimulated an 
increase in plasma gonadotropin levels (Dodd, 1975) and in estrogen and 
androgen (Jenkins and Dodd, 1980). In the lamprey (!.:_ marinus), an 
agnathan fish, an agonist analogue of mammalian GnRH and synthetic 
Tyr3,Leu5,G1u 6 ,Trp 7 ,Lys8-GnRH induced ovulation and increased plasma 
levels of estradiol (Sower et al., 1983, 1985). 
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Table I summarizes the biological activities of GnRHs in different 
vertebrates. 
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TABLE I. BIOLOGICAL ACTIVITY OF VERTEBRATE GnRHs IN DIFFERENT 
VERTEBRATE CLASSES 
GnRH 
Mammalian 
Chicken I 
Chicken II 
Salmon 
Lamprey 
Mammal 
+t+t 
+ 
+t 
+ 
0 
Bird 
+++ 
+++ 
++++ 
+++ 
0 
Reptile 
+t/0 
0 
Amphibian 
++++ 
++++ 
Teleost 
++++ 
++++ 
++++ 
++++ 
Cyclostome 
+t+t 
++++ 
++++ 
Plus signs indicate relative biological activity of GnRH in different 
vertebrates ++++ full activity; +++ high activity; +t intermediate 
activity;+ low activity; O no activity. 
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1.5 BIOSYNTHESIS OF GnRH 
A number of studies have indicated that GnRH is processed from a larger 
precursor molecule to its decapeptide form (Millar et al., 1977; Gautron 
et al., 1981; Curtis and Fink, 1983; Curtis et al., 1983). The cloned 
genomic and cDNA sequences for a precursor form of GnRH have been 
isolated from human placenta (Fig. 2). The DNA sequence coded for a 
protein with 92 amino acids with a 23 amino acid signal peptide preceding 
the GnRH decapeptide sequence and a cleavage site Gly-Lys-Arg following 
the GnRH peptide, with a further 53 amino acids, which formed a peptide 
of unknown function (Seeburg and Adelman, 1984). This peptide seems to 
be a potent inhibitor of prolactin secretion and can stimulate release of 
gonadotropins in rat pituitary cell cultures (Nikolics et al., 1985). 
Since only one GnRH sequence was present in the human placental GnRH 
precursor and a single gene was identified using cDNA probes, it appears 
that only one GnRH form occurs in humans. However, multiple forms of 
GnRH occur in a number of submammalian vertebrates including a bird (King 
and Millar, 1982a, 1982b; Miyamoto et al., 1983, 1984), an amphibian 
(Branton et al., 1982; King and Millar, 1986), a reptile (Powell et al., 
1985) and numerous fish (Jackson and Pan, 1983; Sherwood et al., 1983, 
1984; Idler and Crim, 1985; King and Millar, 1985; Sherwood et al., 
1986), and therefore it seems likely that mammals also have more than one 
form of GnRH. The GnRH may, however, differ from the isolated mammalian 
GnRH to such an extent that the cDNA probes did not detect it. 
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-23 PRE -1 GnRH 
cs 14 27 35 46 53 66 cs 6
9 
Gin His Trp Ser Tyr Gin Leu Arg Pro Gly Gly Lys Arg Lys 
Arg Arg Lys Lys Lys lie 
Fig. 2. Schematic diagram of the structure of
 the human placental GnRH 
precursor as determined by nucleic acid se
quencing of the corresponding 
cDNA (Seeburg and Adelman, 1984). 
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2.0 MATERIALS AND METHODS 
20 
2.1 ANIMALS 
The following animals were used in the study : ostrich (Struthio camelus, 
Aves), alligator (Alligator mississippiensis, 
ocellatus tiligugu, Reptilia), teleost 
Osteichthyes-Teleostei) and do~fish 
Pisces-Chondrichthyes-Elasmobranchii). 
2.2 EXTRACTION PROCEDURES 
2.2.1 Ostrich hypothalami 
Reptilia), skink (Calcides 
(Coris julis, Pisces 
(Poroderma africanum, 
Brains were removed from three hundred and sixty ostriches and the 
hypothalami were dissected within 20 min of death, frozen on dry ice and 
stored at -7o0 c. They were homogenized in ice-cold 2N acetic acid 
containing 10-3 M phenylmethane-sulphonylfluoride (PMSF) and centrifuged 
for 90 min at 18 000 x g at 4°c. The supernatant was decanted and the 
pellet re-extracted with 2N acetic acid. The combined supernatants were 
lyophilized and stored at -20°c. 
2.2.2 Alligator brains 
Brains were removed from twenty-three freshly-killed animals killed in 
the legal hunting season in Louisiana, lyophilized, and homogenized in 
ice-cold 2N acetic acid containing 10-4 M hac1trac1n and 10-3 M PMSF. 
The homogenate was boiled 
at 18 000 X g at 4°C. 
for 10 min, chilled, and centrifuged for 1 hr 
The supernatant was decanted, the pellet 
re-extracted and the pooled supernatants defatted with petroleum ether 
(40-60°C) (2 x vol) at 4°C for 1 hr, lyophilized and stored at -20°c. 
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2.2.3 Skink brains 
Brains were removed from four animals, lyophilized, homogenized in 
ice-cold 2N acetic acid, and centrifuged for 1 hr at 18 000 x g at 4°C. 
The supernatant was lyophilized (provided hy G. Ciarcia, Department of 
Evolutive and Comparative Biology, University of Naples, Italy). 
2.2.4 Dogfish tissues 
Twenty pituitaries, hypothalami and extrahypothalamic brains were 
dissected within 24 hr of capture in March (Batch A), eighty-two whole 
brains were dissected in April (Batch B), and a further one hundred and 
nine whole brains were dissected in October (Batch C). The tissues were 
lyophilized and Batches A and B homogenized with ice-cold 2N acetic acid 
containing 10-4 M hacitracin and 10-3 M PMSF. The homogenates were 
centrifuged for 1 hr at 18 000 x g at 4°c. Supernatants were decanted 
and pellets re-extracted in ice-cold 2N acetic acid containing 10-3 M 
PMSF. Batch C was homogenized with 2N acetic acid containing 10-3 M 
PMSF, the homogenate boiled for 10 min, chilled, and centrifuged for 1 hr 
at 18 000 X g at 4°c. The pellet was re-extracted and superna tan ts were 
pooled and defatted with petroleum ether (40-60°C) (2 x vol). All the 
supernatants were lyophilized and stored at -20°c. Dogfish systemic 
blood was collected in March and October (10 ml and 7 ml, respectively). 
The cells were spun down and the supernatants extracted with acetone (4 x 
vol) in 2N acetic acid at 4°c. The extracts were centrifuged at 18 000 x 
g for 1 hr at 4°C. The supernatants were lyophilized and assayed for 
immunoreactive GnRH in serial dilutions. The presence of binding 
substances and peptidases in the serum extract was investigated. 
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2.2.5 Teleost brain 
Eight brains were dissected, lyophilized, and homogenized with ice-cold 
2N acetic acid and centrifuged for 1 hr at 18 000 x g at 4°C. The 
supernatant was lyophilized (provided by G. Ciarcia). 
2.3 CHROMATOGRAPHY 
2.3.1 Gel filtration 
The tissue extract was reconstituted in 2N acetic acid, sonicated, and 
applied to a Sephadex G-25 
equilibrated with 2N acetic acid 
fine (5 
at 4°C. 
x 85 cm; Pharmacia) column 
One hundred 20-ml fractions 
were collected, using 2N acetic acid as solvent. The void volume (Vo) 
and salt elution volume (Vs) were assessed using bovine serum albumin and 
sodium chloride, respectively. The elution volume of the immunoreactive 
GnRH was compared with that of synthetic mammalian GnRH. Aliquots of 
fractions were lyophilized and assayed 
against 
by radioimmunoassay with 
region-specific antisera generated three of the known 
naturally-occurring GnRHs. 
2.3.2 Semipreparative high performance liquid chromatography 
Samples were eluted on a Lichrosorb RP 18 column (0.16 x 25 cm; 10 um 
particle size; Chrompack) using 0.01 M ammonium acetate, pH 4.0 (A) and 
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60% acetonitrile in 0.01 M ammonium acetate pH 4.0 (B) as solvents. The 
conditions used were : 40% B for 20 min, followed by a gradient from 40 
to 55% B for 5 min, 25 min at 55% B, a 5-min gradient from 55 to 99% B 
and 5 min at 99% B. Flow rate was 8 ml/min and sixty 1-min fractions 
were collected. Aliquots of fractions were lyophilized and assayed with 
region-specific antisera. 
2.3.3 Analytical high performance liquid chromatography 
Sys tern 1. Samples were eluted on a Vydac Cl8 reverse phase column (no 
1) (0.46 x 25 cm; 5 um particle size; The Separations Group) with 30% B 
in A+ B for 10 min, B being 60% acetonitrile in 0.1% heptafluorobutyric 
acid and A being 0.1% heptafluorobutyric acid. This was followed by a 
gradient from 30 to 50% B for 20 min, then isocratically at 50% B for 10 
min. This was followed by a 5-min gradient from 50 to 99% Band 5 min at 
99% B. Flow rate was 1.5 ml/min. Fifty 1-min fractions were collected. 
Aliquots of fractions were lyophilized and assayed with various 
region-specific GnRH antisera. 
System 2. The sample was eluted on a second Vydac Cl8 reverse phase 
column (no 2) (0.46 x 25 cm; 5 um particle size; The Separations Group) 
using the same solvent system as in system 1. 
System 3. The sample was eluted on a Spherisorb ODS reverse phase column 
(no 1) (0.4 x 25 cm; 5 um particle size; Phase Separations) with 40% Bin 
A+ B for 20 min, A being 0.01 M ammonium acetate, pH 4.0, and B being 
60% acetonitrile in 0.01 M ammonium acetate, pH 4.0. This was followed 
24 
by a 5-min gradient from 40 to 60% B, 25 min at 60% B, a 5-min gradient 
from 60 to 99% Band 5 min at 99% B. Flow rate was 1.5 ml/min. Sixty 
1-min fractions were collected. Aliquots of fractions were lyophilized 
and assayed with various region-specific GnRH antisera. 
System 4. The sample was eluted on a second Spherisorb ODS reverse phase 
column (no 2) (0.4 x 25 cm; 5 um particle size; Phase Separations) with 
40% Bin A+ B for 20 min, A being 0.01 M ammonium acetate, pH 4.0, and B 
being 60% acetonitrile in 0.01 M ammonium acetate, pH 4.0. This was 
followed by a 10-min gradient from 40 to 60% B, 20 min at 60% B, a 5-min 
gradient from 60 to 99% Band 5 min at 99% B. Flow rate was 1.5 ml/min. 
Sixty 1-min fractions were collected. Aliquots of fractions were 
lyophilized and assayed with various region-specific GnRH antisera. 
System 5. The sample was eluted on a Vydac Cl8 reverse phase column (no 
4 
2) (0.46 x 25 cm; 5 um particle size; The Separations Group) with 27% B 
in A + B for 10 min, A being 0.1% heptafluorobutyric acid and B being 60% 
acetonitrile in 0.1% heptafluorobutyric acid. This was followed by a 
20-min gradient from 27 to 50% B, 10 min at 50% B, a 5-min gradient from 
50 to 99% Band 5 min at 99% B. Flow rate was 1.5 ml/min. Fifty 1-min 
fractions were collected. Aliquots of fractions were lyophilized and 
assayed with region-specific GnRH antisera. 
Mammalian GnRH (R.C. deL. Milton, University of Cape Town, Cape Town, 
South Africa), Gln8-GnRH (R.W. Roeske, Indiana University, Indianapolis, 
IN), Trp 7 ,Leu8-GnRH (J.E. Rivier, The Salk Institute, La Jolla, CA) and 
His 5 ,Trp 7 ,Tyr8-GnRH (R.C. aeL. Milton) were chromatographed on these HPLC 
systems as standards. To ensure that columns were not contaminated with 
synthetic GnRHs, each run of biological material was preceded by a blank 
run and was assayed for GnRH immunoreactivity with antiserum 80/1 which 
cross-reacts with all four of these GnRH forms (King and Millar, 1985). 
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2.4 RADIOIMMUNOASSAY OF GnRH 
Immunoreactive GnRH in the samples was measured as described by Millar et 
al., 1984. 
2.4.1 Region-specific antisera 
Antisera 80/1 (S. Blahser, Institut fUr Anatomie und Zytobiologie, 
Giessen, Germany) and 1076 (King and Millar, 1980) were generated against 
mammalian GnRH, antiserum 303 was generated against Gln8-GnRH (King~ 
al., 1983) and antiserum 802 was generated against Trp 7,Leu8-GnRH (Powell 
et al., 1985). 
Figure 3 indicates the regions of the decapeptide required for effective 
binding by these antisera. 
(King et al., 1983). 
Antiserum 80/1 requires pGlu 1 and Gly10NH 2 
Substitutions of Gly6 with bulky amino acids are 
not tolerated as the conformation of GnRH (Fig. 4) is affected by these 
substitutions. Antiserum 1076 requires the region Trp 3 to Pro9 of GnRH 
(King and Millar, 1982b); antiserum 303 requires Gln8 as in Gln8-GnRH 
(King et al. , 
Trp 7,Leu8-GnRH 
1983) and antiserum 802 requires 
(J.A. King and R.P. Millar, 
Trp7 and Leu8 as in 
unpublished). The 
sensitivities (half-maximal displacement of iodinated peptide) in the 
radioimmunoassay with antisera 80/1, 1076, 303 and 802 are given in Table 
II. 
2.4.2 Radio-iodination of GnRH with 125 I 
Synthetic mammalian GnRH, Gln8-GnRH and Trp 7,Leu8-GnRH (J.E. Rivier) were 
labelled with 125 1 using a modification of the cbloramine-T method 
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1 2 3 4 5 6 7 8 9 10 
GnRH pGlu.His.Trp.Ser .Tyr.Gly. Leu.Arg. Pro.Gly.NH2 
Antiserum 80/ 1 ~ 
Antiserum 1076 
~ ~ 
~------ ~---------~ 
~------..WLm..---------~ 
8 
Gln8-GnRH -------------Gin-------
Antiserum 303 
7 8 
------'----~--Trp. Leu-------
Antiserum 802 
Fig. 3. Regions of the mammalian GnRH, Gln8-GnRH and Trp 7,Leu8-GnRH 
molecules which are known to be essential for full immunoreactivity with 
antisera 80/1, 1076, 303 and 802. 
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(Millar et al.' 1984) 12 5I-GnRH was purified on a CM32 
carboxymethylcellulose cation exchange column (1 x 20 cm; Whatmao) with 
0.002 M ammonium acetate, pH 4.6, for 20 ml and then with 0.06 M ammonium 
acetate, pH 4.6 (Millar et al., 1984). It was used in the 
radioimmunoassay with the antisera 80/1 and 1076. 
125 I-Trp 7 ,Leu8-GnRH 
was purified on the same column with a gradient from 0.01 M ammonium 
acetate, pH 4.6, to 0.1 M ammonium acetate, pH 4.6. It was used with 
antiserum 802. 125 I-Gln8-GnRH was purified on a Sep-Pak C-18 cartridge 
(Waters Associates), pre-washed with methanol and water. The iodinated 
peptide was eluted with a gradient of 20 to 50% acetonitrile in 0.002 M 
ammonium acetate, pH 4.6, over 15 ml (King et al., 1983). It was used 
with antiserum 303. Fractions containing the iodinated peptides were 
pooled and stored at -20°c. 
2.4.3 Radioimmunoassay protocol 
Aliquots of gel filtration and HPLC fractions were reconstituted in 100 
ul phosphate-buffered saline (PBS) containing gelatin (0.04 M 
NaH2Po 4 .2H20, 0.15 M NaCl, 0.01 M
 disodium ethylenediaminetetra acetic 
acid, 0.015 M NaN 3 , pH 7.0, with 0.1% gela
tin). Standard (mammalian 
GnRH, Gln8-GnRH or Trp 7 ,Leu8-GoRH) was reconstituted in PBS-gelatin 
buffer and serially diluted. 100 µl of standard or sample, 200 µl 
PBS-gelatin buffer and 100 µ1 of antiserum (final dilutions given in 
Table II) were preincuhated in glass test-tuhes for 15 min at 20°c. 100 
µl of the appropriate iodinated peptide (10 000 cpm) was added and the 
tubes were incubated overnight at 4°c. Separation of antibody-bound and 
free iodinated peptide was achieved by adding 750 Jll ctextran-coated 
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Fig. 4. The proposed conformation of GnRH. 
Antiserum 
80/1 
1076 
303 
802 
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TABLE II. GnRH RADIOIMMUNOASSAY CHARACTERISTICS 
Final dilution 
1:12 000 
1:100 000 
1: 2 000 
1: 1 250 
Half-maximal displacement 
(pg) 
32.5 
15.7 
361 
582 
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charcoal (0.5% charcoal, 0.05% dextran), incubating at 4°C for 15 min, 
and centrifuging at 3 000 x g at 4°C for 15 min. Supernatants were 
poured over and counted in a gamma counter. Mammalian GnRH was used as 
standard with antisera 80/1 and 1076; Gln8-GnRH with antiserum 303 and 
Trp 7 ,1eu8-GnRH with antiserum 802. 
2.5 TESTS FOR PEPTIDASES AND BINDING SUBSTANCES 
To test for peptidase activity the tissue extract was incubated with 
mammalian 1251-GnRH at 20°c. Aliquots were removed at 30-min intervals 
for 3 hr and binding with excess antiserum 1076 was determined as in a 
radioimmunoassay. To test for binding 
incubated with mammalian 12 5I-GnRH at 
substances, the extract was 
4°c overnight in the absence of 
antiserum and the radioimmunoassay was performed as usual. 
2.6 LH-RELEASING ACTIVITY IN CHICKEN DISPERSED ANTERIOR PITUITARY CELLS 
The LH-releasing activity in the HPLC fractions was measured by 
incubating aliquots of fractions (or pools of fractions) with chicken 
dispersed anterior pituitary cells (Millar and King, 1983) and measuring 
the LH content in the cell medium by radioimmunoassay (Follett et al., 
1972). 
Anterior pituitaries were dissected from chicken heads collected on ice 
within 2 hr of death, and placed in ice-cold sterile Romanoff's avian 
Ringer's Albumin buffer (RRA) (147 mM NaCl, 4.15 mM KC!, 1.8 mM CaC1 2 , 
0.49 mM MgC12 .6H20, 1.5 mM KH 2Po 4, 2.2 mM Na 2HP0 4 .12H2o, 
11.1 mM glucose 
and 0.5% BSA, pH 7.2). The pituitaries were minced with a razor blade 
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and the fragments incubated with 10 ml Hepes buffer (137 mM NaCl, 5 mM 
KC!, 0.7 mM 25 mM 4-2-hydroxyethyl pipe
razine 
ethaoesulphonic acid, 0.36 mM CaClz, 10 mM glucose, and 0.1% BSA, pH 7.2) 
containing 0.9% collagenase and 1.8 mg/dl deoxyribonuclease for 1 hr at 
37°c. The suspension was then passed up and down a sterile 10 ml pipette 
to assist dispersion, centrifuged at 500 x g for 5 min, and the pellet 
was re-suspended in RRA at 20°c. The cells were washed a further two 
times in RRA and filtered through a Baxter 'Plexitron' nylon mesh. The 
cells were distributed into polypropylene tubes (12 X 75 mm) at a 
concentration of approximately 0.7 pituitary equivalents per tube. The 
tubes were preincubated in 1. 5 ml RRA for 20 min at 37°c with gentle 
shaking under a 90% water-saturated atmosphere of 4% CO 2 - 96% air. The 
cells were centrifuged at 500 X g for 5 min, and the supernatant poured 
off. HPLC fractions and synthetic Gln8-GnRH were diluted in RRA and 
added to the cells in triplicate in a volume of 1.0 ml. The tubes were 
incubated for 2 hr at 37°c and centrifuged at 500 X g for 5 min, the 
supernatant poured over into polypropylene tubes and re-centrifuged at 
500 x g for 5 min. An aliquot of the final supernatant was assayed for 
LH immunoreactivity. 
2.7 RADIOIMMUNOASSAY OF CHICKEN LH 
Immunoreactive LH was measured as described by Follett et al.(1972). 
2.7.1 LH antiserum 
Antiserum 16/6 (B.K. Follett, University of Bristol, Bristol, U.K.) was 
raised against chicken pituitary LH in a rabbit. 
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2.7.2 Preparation of 1251-labelled chicken luteinizing hormone 
Purified chicken LH (B.K. Follett; P. Sharp, AFRC Poultry Research 
Centre, Midlothian, Scotland) was lahelled with 12 51 using chloramine-T 
(Follett et al., 1972). The labelled LH was purified by adsorption 
chromatography on a column (0.5 x 2 cm) of CFll cellulose (Whatman) with 
40 ml 0.12 M barbiturate buffer (pH 8.6) and 10 ml human plasma, 
collecting 1 ml fractions. Fractions containing 125 1-LH were pooled and 
stored at -20°c. 
2.7.3 Radioimmunoassay protocol 
A double an tihody technique of radioimmunoassay was performed in 
disposable polystyrene tuhes (12 x 75 mm). Standard (produced by 
stimulating chicken pituitary cells with 10-6 M Gln8-GnRH) or sample was 
made up to 300 pl of PBS-gelatin buffer. 100 µl of antiserum 16/6 (1:30 
000) was added and tuhes were preincubated for 15 min at 20°c. 100)11 
1251-LH (10 000 cpm) was added and the tubes were incubated overnight at 
4°C. Separation of antibody-bound and free 1251-LH was achieved by 
adding 100 pl of Sac-Cel (donkey anti-rabbit, antibody-coated cellulose 
suspension; Wellcome), incubating at 20°c for 30 min, adding 1 ml of 
water and centrifuging at 2000 x g for 5 min. 
aspirated and the pellet counted in a gamma counter. 
The supernatant was 
[i 
Ii 
; 
I 
I 
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p 
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3.0 IDENTIFICATION OF G!n8-GnRH, His 5,Trp 7,Tyr8-GnRH AND NOVEL 
FORMS OF GnRH ,IN THE HYPOTHALAMUS OF THE OSTRICH 
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3.1 ABSTRACT 
Gonadotropin-releasing hormone molecular forms were studied in ostrich 
(S. camelus) hypothalamic extract using gel filtration, HPLC, 
radioimmunoassay with region-specific GnRH antisera and by assessment of 
LH-releasing activity usin~ chicken dispersed anterior pituitary cells. 
Two molecular forms of 
biological properties 
His 5 ,Trp7 ,Tyr8-GnRH were 
GnRH with 
identical 
chromatographic, 
to those of 
immunological 
Gln 8-GnRH 
demonstrated in the hypothalamic extract. 
and 
and 
Three 
additional novel LH-releasing factors, which did not cross-react with the 
GnRH antisera used, were identified. 
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3.2 INTRODUCTORY STATEMENT 
Cnicken hypothalamic GnRHs have heen isolated and cnar.acterized as 
Gln8-GnRH (King and Millar, 1982a, 1982c; Miyamoto et al., 1983) and 
His 5 ,Trp7,Tyr8-GnRH (Miyamoto ~ al., 1984). Hypothalamic immunoreactive 
GnRH has also been described in a number of other birds (King and Millar, 
1979a; Hattori ~ al., 1980; King and Millar, 1980; Weindl et al., 1982), 
hut the structure of the GnRHs in these birds is not known. 
therefore, necessary that GnRH in another bird is studied. 
It is, 
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3.3 RESULTS 
Chromatography and radioimmunoassay of ostrich hypothalamic extract 
The concentration of immunoreactive GnRH in the hypothalamus was 18.9 
pg/mg dry weight of extract (1.08 ng/hypothalamus) according to N- and 
C-terminus-directed antiserum 80/1, 
On gel filtration chromatography, immunoreactive GnRH (antiserum 80/1) 
co-eluted with decapeptide mammalian GnRH as a broad peak (Fig. 5). This 
suggests that the GnRH is a decapeptide with blocked N- and C-termini 
(antiserum 80/1 requirements for effective binding). 
peak was pooled and lyophilized. 
The immunoreactive 
Semipreparative HPLC of decapeptide-sized immunoreactive GnRH resolved 
three immunoreactive peaks (antiserum 80/1) (Fig. 6). The 
middle-directed antiserum 1076 cross-reacted 73% with peak I, 17% with 
peak II and 9.2% with peak III (relative to antiserum 80/1). The 
relative cross-reactivities of synthetic analogues of the five known 
naturally-occurring GnRHs are given in Table III. It seems possible, 
therefore, that peak II is Gln8-GnRH. The three peaks were pooled 
separately. 
On analytical HPLC (system 5), peak I (from semipreparative HPLC) eluted 
as two peaks of immunoreactive GnRH (antiserum 80/1) (Fig. 7). The first 
peak did not co-elute with any of the known naturally-occurring GnRHs; 
the second peak co-eluted with Gln8-GnRH. As peak II (from 
semipreparative HPLC) also co-eluted with Gln8-GnRH, this is likely to · be 
due to overlapping of the peaks (on semipreparative HPLC) when pooling 
fractions. 
Fig. 5. 
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Fig. 7. Analytical HPLC of ostrich hypothalamus immunoreactive peak I 
(system 5, 854 pg GnRH, recovery was 145 %, antiserum 80/1). Fractions 
were assayed with antiserum 80/1. Elution positions of Gln
8
-GnRH (1), 
mammalian GnRH (2), Trp 7 ,Leu8-GnRH (3) and His5,Trp 7 ,Tyr8-GnRH (4) are 
indicated. 
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Peak II eluted as a single peak of immunoreactive GnRH (antiserum 80/1) 
on HPLC system 2, but eluted earlier than any of the four known 
naturally-occurring GnRHs (Fig. 8A). This was due to overloading of the 
column and the peak was thus pooled, lyophilized, and reapplied to the 
same system (Fig. 8B). The peak again eluted early (Fig. 8B). Fraction 
eight was lyophilized and half of the lyophilizate was reapplied to HPLC 
system 2. Immunoreactive GnRH eluted as a single peak (antiserum 80/1) 
(Fig. 8C), which co-eluted with Gln8-GnRH. The other half of the 
lyophilizate was applied to HPLC system 4, where the 
again co-eluted with Gln8-GnRH (antiserum 80/1) 
molecular form also cross-reacted with antiserum 303 
immunoreactive GnRH 
(Fig. 9). This GnRH 
(123% relative to 
antiserum 80/1) 
immunoreactivity. 
(Fig.9), which requires Gln8 (Table III) 
These data suggest that peak II is Gln8-GnRH. 
for full 
Peak III (semipreparative HPLC) eluted as a single peak of 
immunoreactivity (antiserum 80/1) on HPLC system 2 (Fig. lOA). This peak 
did not co-elute with any of the four known naturally-occurring GnRHs, 
due to overloading of the column. The peak was, therefore, pooled and 
reapplied to the same system. The immunoreactive GnRH eluted as two 
peaks (antiserum 80/1) (Fig. lOB); 
mammalian GnRH and the second peak with 
the first peak co-eluting with 
His 5 ,Trp 7 ,Tyr8-GnRH. Antiserum 
1076 cross-reacted 16% with the first peak (relative to antiserum 80/1, 
data not shown). This suggests that it is not mammalian GnRH, which 
cross-reacts equally with antisera 80/1 and 1076 (Table III). 
42 
A 1 24 3 100 
' ' ' ' 
100 
80 80 
60 : 60 
·· ··· ···· ··· 
: 
40 40 
..... 
20 20 
0 0 
I I 
r"'\ 
C: B 0 1 24 3 
-
-100 (.) 
' ' ' ' 
ro 
~ 80 
-
.... 
- 80 
' 
co 
g> 60 ... - 60 I-
"-J 
···· ·········· · 
z 
40 
.... 
- 40 w 
:I: .... .... > 
a: ........ .. ....J 
C: 20 .... - 20 0 c., (/) 
Q.) 0 - 0 
~o > 
-
0 
(.) 
ro 
Q.) C ~ 
0 1 24 3 ....... 100 C: 
:::, 
' ' ' ' 
E 80 80 
E 60 60 
.... ····· ·· ··· ·· ·· 
40 40 
······ ·· ··· . 
20 20 
0 0 
0 10 20 30 40 50 
TIME (min) 
Fig. 8. Analytical HPLC of ostrich hypothalamus immunoreactive peak II 
(system 2). A. 64 ng GnRH, recovery was 145%, antiserum 80/1. B. 76 
ng GnRH, recovery was 95 %, antiserum 80/1. C. 69.7 ng GnRH, recovery 
was 82%, antiserum 80/1. Fractions were assayed with antiserum 80/1. 
Elution positions of Gln8-GnRH (1), mammalian GnRH (2), Trp 7 ,Leu8-GnRH 
( 3 ) and His 5 ,Trp 7 ,Tyr8-GnRH (4) are indicated. 
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positions of Gln
8
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Analytical HPLC of ostrich hypothalamus imm
unoreactive peak III 
(system 2). A. 4.3 ng GnRH, recovery was 109.6%, a
ntiserum 80/1. B. 
6.3 ng GnRH, recovery was 89%, antiserum
 80/1. Fractions were assayed 
with antiserum 80/1. Elution positions of G
ln8-GnRH (1), mammalian GnRH 
(2), Trp7,Leu8-GnRH (3) and His5,Trp 7,Tyr8-GnRH (4) ar
e indicated. 
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Chicken LH-releasing activity 
The peak which co-eluted with Gln 8-GnRH (peak II from semipreparative 
HPLC) stimulated the release of LH (Fig. 11). The amount of LH released 
the peak is consistent with 
His 5 ,Trp7 ,Tyr8-GnRH was twice 
His 5 ,Trp 7 ,Tyr8-GnRH 
being Gln8-GnRH. 
as potent as 
is 5 times more 
The peak coincident with 
Gln8-GnRH (Fig. 12). 
potent than synthetic Synthetic 
Gln8-GnRH (Millar and King, 1984; Chou et al., 1985). These results thus 
demonstrate that two GnRHs in ostrich hypothalamus are likely to be 
Gln 8-GnRH and His 5 ,Trp7,Tyr8-GnRH. The peak coincident with mammalian 
GnRH (0.44 ng, antiserum 80/1) released a substantial amount of LH (Fig. 
12), which is not consistent with the peak being mammalian GnRH as a 
similar amount of synthetic mammalian GnRH would release far less LH. 
Therefore, this is a novel GnRH molecular form. Three additional peaks 
of LH-releasing activity were demonstrated (Fig. 12), which displayed no 
immunoreactivity with antiserum 80/1. These peaks are likely to be novel 
forms of GnRH which do not cross-react with the antiserum, or 
structurally-unrelated peptides which have LH-releasing activity. 
Fig. 11. 
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Chicken pituitary cell bioassay. 
40 50 M 
A. Effect of ostrich 
hypothalamic peak II GnRH (Fig. 8C) in HPLC pooled fractions (system 2) 
and 10-7 M Gln8-GnRH (maximal stimualtion, M) on LH release from 
dispersed chicken pituitary cells. LH release is expressed as ug LH/ml 
of cell medium with basal release subtracted (open column). Columns 
represent the mean + SEM (n = 3) of a pool of HPLC fractions (in twos). 
Immunoreactive GnRH (antiserum 80/1) per HPLC fraction pool taken for the 
bioassay is expressed as ng GnRH/aliquot of HPLC fraction pool (dotted 
column). Elution positions of Gln8-GnRH (1), mammalian GnRH (2)' 
Trp7 ,Leu8-GnRH (3) and His 5 ,Trp7 ,Tyr8-GnRH (4) are indicated. 
Fig. 12. 
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Chicken pituitary cell bioassay. 
40 50 M 
A. Effect of ostrich 
hypothalamic peak III GnRH (Fig. lOB) in pooled HPLC fractions (system 2) 
and 10-? M Gln8-GnRH (maximal stimulation, M) on LH release from 
dispersed chicken pituitary cells. LH release is expressed as ug
 LH/ml 
of cell medium with basal release subtracted (open column), Columns 
represent the mean+ SEM (n = 3) of a pool of HPLC fractions (in twos). 
Immunoreactive GnRH (antiserum 80/1) per HPLC fraction pool taken for the 
bioassay is expressed as ng GnRH/aliquot of HPLC fraction pool 
(dotted 
column). Elution positions of Gln8-GnRH (1), mammalian GnRH (2), 
Trp 7 ,Leu8-GnRH (3) and His 5 ,Trp 7 ,Tyr8-GnRH (4). 
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3.4 DISCUSSION 
Two immunoreactive GnRH molecular forms were identified in ostrich 
hypothalamus. One form co-eluted with Gln8-GnRH in two analytical HPLC 
systems employing different columns and solvents, which separate the 
known vertebrate GnRHs and a wide range of GnRH analogues. The 
interaction of this GnRH with three region-specific antisera was 
identical to that of Gln8-GnRH and, moreover, this peak stimulated 
release of LH similarly to synthetic Gln8-GnRH. These data strongly 
suggest that one form of GnRH in ostrich hypothalamus is Gln8-GnRH. The 
second immunoreactive (antiserum 80/1) GnRH molecular form co-eluted with 
His5,Trp7,Tyr8-GnRH on analytical HPLC and did not cross-react with 
antiserum 1076. It released twice as much LH from chicken anterior 
pituitary cells than the peak which co-eluted with Gln 8-GnRH, and thus 
had similar chromatographic, 
His 5 ,Trp7,Tyr8-GnRH. Four 
immunological and biological properties to 
additional LH-releasing substances were 
present. One of these forms co-eluted with mammalian GnRH in an HPLC 
system, but had different immunological and biological properties. The 
other three forms are novel GnRH molecular forms with low 
immunoreactivity, or unrelated peptides with LR-releasing activity. 
Since Gln8-GnRH and His 5 ,Trp7 ,Tyr8-GnRH occur in both chicken (King and 
Millar, 1982a, 1982c; Miyamoto et al., 1983, 1984) and ostrich 
hypothalamus, it appears that these two GnRHs are conserved in birds. 
However, since other novel GnRHs are present in the ostrich hypothalamus, 
it appears that diversity in GnRH structure does occur in birds. 
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4.0 DIVERSE MOLECULAR FORMS OF GnRH IN REPTILE BRAIN 
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4.1 ABSTRACT 
Gonadotropin-releasing hormone molecular forms in the brains of two 
reptiles, A. mississippiensis (alligator) and C. ocellatus tili~ugu 
(skink) were characterized by HPLC and radioimmunoassay with 
region-specific GnRH antisera, and by assessment of LH-releasing activity 
in chicken dispersed anterior pituitary cells. In alligator brain, two 
GnRHs had identical properties to the two known forms of chicken 
hypothalamic GnRH (Gln8-GnRH and His 5 ,Trp7 ,Tyr8-GnRH) in their elution on 
two reverse phase HPLC systems, cross-reaction with region-specific GnRH 
antisera, and ability to release LH. In skink hrain, one immunoreactive 
and bioactive GnRH form, which co-eluted with His 5 ,Trp7 ,Tyr8-GnRH on 
reverse phase HPLC, was identified. 
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4.2 INTRODUCTORY STATEMENT 
Amongst reptiles, in lizard (C. nigra) brain four GnRHs have been 
partially characterized using HPLC, radioimmunoassay with region-specific 
antisera and assessment of chicken LH-releasing activity (Powell et al., 
1985). Two of these forms had identical properties to Trp 7 ,Leu8-GnRH and 
whereas other forms appear to be novel GnRHs. 
Immunoreactive GnRHs in lizard (.!'.!..:_ capens~) and tortoise (C. angulata) 
hypothalami were immunologically different from mammalian GoRH (King and 
Millar, 1979a, 1980); however, their structures have not been studied 
further. Alligator (A. mississippiensis) hypothalamic GnRH was studied 
using two region-specific GnRH antisera. The GnRH differed from the 
mammalian peptide in at least the 8 position (Lance, 1985; Lance et al., 
1985). Therefore, there is very little data concerning GnRHs in 
different reptilian species. 
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4.3 RESULTS 
Alligator. brain extract 
Chromatography and radioimmunoassay of alligator brain extract 
Immunoreactive GnRH content and concentration are given in Table IV. 
Immuooreactive GnRH (antiserum 80/1) eluted as a broad peak (Fig. 13), 
coincident with synthetic mammalian GnRH on gel filtration, indicating 
that they have the same molecular size. The data suggest that the GnRH 
is a decapeptide with blocked N- and C-termini as in mammalian GnRH 
(antiserum 80/1 requires the N- and C-termini for binding). The first 
fifty fractions were also assayed with middle-directed antiserum 1076 to 
determine the possible presence of high molecular weight GnRH (a 
precursor or GnRH bound to a protein) (data not shown). No 
immunoreactivity was detected, indicating that there is no high molecular 
weight GnRH or that the antiserum does not cross-react with it. The 
immunoreactive GnRH peak was pooled and lyophilized. 
The pooled lyophilized fractions from the gel filtration column were 
reconstituted in water and sonicated for analytical HPLC. A portion of 
the sample was applied to HPLC system 1. A single peak of immunoreactive 
GnRH (antiserum 80/1) co-eluted with synthetic Gln8-GnRH (Fig. 14). It 
was well-separated from the other three naturally-occurring GnRHs. This 
immunoreactive GnRH also cross-reacted with antiserum 303 (114% relative 
to cross-reaction with antiserum 80/1) (Fig. 14). This antiserum 
requires Gln8 for full cross-reaction. It is known that Gln8-GnRH 
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TABLE IV. CONTENT AND CONCENTRATION OF IMMUNOREACTIVE GnRH (ANTISERUM 
(80/1) IN REPTILE BRAIN 
Species Tissue 
Alligator whole brain 
Skink whole brain 
Immunoreactive GnRH 
(ng/Ussue) 
14.6 
0.1 
(pg/mg dry weight 
of tissue) 
19.3 
7.9 
Fig. 13. 
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cross-reacts fully with antisera 80/1 and 303 (King et al., 1983) (Table 
8 
III). Therefore, the data strongly suggest the presence of Gln -GnRH in 
alligator brain. 
The remaining sample was applied to HPLC system 1 in two runs (Fig. 15). 
Two immunoreactive GnRH peaks (antiserum 80/1) eluted in each of the 
runs. Peak I (the major immunoreactive peak) and peak II co-eluted with 
Gln8-GnRH and His5,Trp7,Tyr8-GnRH, respectively. His5,Trp 7 ,Tyr8-GnRH 
cross-reacts only 5% with antiserum 80/1 (relative to mass) (King and 
Millar, 1985). Thus peak II could contain 40.5 ng (Run A) (Fig. 15A) and 
10.4 ng (Run B) (Fig. 15B) of His5,Trp7,Tyr8-GnRH. Run B fractions were 
also assayed with middle-directed antiserum 1076 (Fig. 15B). Peak I 
cross-reacted 12% with antiserum 1076 (relative to antiserum 80/1) which 
is similar to the relative cross-reaction of Gln8-GnRH with these two 
antisera (King and Millar, 
antiserum 1076 (Fig. 
1982b). Peak II 
15B). This is 
did not 
similar 
cross-react with 
to the relative 
cross-reaction of His 5 ,Trp 7 ,Tyr8-GnRH with these two antisera. Antiserum 
1076 cross-reacts only 0.1% with His 5 ,Trp 7 ,Tyr8-GnRH (relative to mass) 
(King and Millar, 1985). The two immunoreactive GnRH peaks in Run A were 
pooled separately and lyophilized for further analytical HPLC. Aliquots 
of Run B fractions were lyophilized for assessment of LH-releasing 
activity in the chicken anterior pituitary cell bioassay. 
The two peaks from Run A, HPLC system 1, were rechromatographed 
separately on 
with Gln8-GnRH 
HPLC system 3 
(Fig. 16A) 
(Fig. 16). Peaks I and II again co-eluted 
and His 5 ,Trp 7 ,Tyr8-GnRH (Fig. 16B) 
respectively, and were well-separated from the other naturally-occurring 
GnRHs. These data provide further evidence for the presence of Gln8-GnRH 
and His 5 ,Trp7 ,Tyr8-GnRH in alligator brain. 
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Fig. 15. Analytical HPLC of alligator brain immunoreactive GnRH (system 
1). A. 62 ng GnRH, recovery was 150%, antiserum 80/1. Fractions were 
assayed with antiserum 80/1 (..--.) B. 62 ng GnRH, recovery was 145%, 
antiserum 80/1. Fractions were assayed with antisera 80/1 (..--.) and 1076 
( ........... ) . Elution positions of Gln8-GnRH (1), mammalian GnRH (2), 
(3) and His5,Trp7,Tyr8-GnRH (4) are indicated. The 
inserts represent a twenty-fold magnification of peak II. 
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Fig. 16. Analytical HPLC of alligator brain immunoreactive GnRH peaks 
from system 1 on system 3. A. 11.1 ng peak I GnRH, recovery was 119%, 
antiserum 80/1. Fractions were assayed with antiserum 80/1. B. 413 pg 
peak II GnRH, recovery was 80%, antiserum 80/1. Fractions were assayed 
with antiserum 80/1. Elution positions of Gln8-GnRH (1), mammalian GnRH 
(2), Trp 7 ,Leu8-GnRH (3) and His 5 ,Trp 7 ,Tyr8-GnRH (4) are indicated. 
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Chicken LH-releasing activity 
Both immunoreactive GnRH peaks (antiserum 80/1) stimulated chicken LH 
release (Fig. 17). Peak I (5.1 ng immunoreactive GnRH, antiserum 80/1) 
released 6.36 µg of LH. 
antiserum 80/1) released 3.53 
Peak II (0.075 ng immunoreactive GnRH, 
pg of LH. His 5 ,Trp 7 ,Tyr8-GnRH has been 
shown to he 5 times more potent than Gln 8-GnRH in stimulating chicken LH 
release (Millar and King, 1984; Chou et al., 1985). Thus peak II (if it 
were His 5 ,Trp7,Tyr8-GnRH) would be twice as potent as peak I. This is 
consistent with the two GnRHs being Gln8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH. 
Skink brain extract 
Chromatography and radioimmunoassay of skink brain excract 
Immunoreactive GnRH content and concentracion are given in Table IV. On 
analycical HPLC syscem 2, a single immunoreactive GnRH peak eluted (396 
pg, antiserum 80/1) (Fig. 18), coincident with His 5 ,Trp 7 ,Tyr8-GnRH. If 
the peak were His 5 ,Trp7,Tyr8-GnRH, it would contain 7.9 ng GnRH (by 
mass), as this GnRH analogue cross-reacts only 5% with antiserum 80/1 
(King and Millar, 1985). This peak of GnRH was well-separated from the 
other three naturally-occurring GnRHs chromatographed on chis system. 
Chicken LH-releasing activity 
The LH-releasing activity of the above HPLC fraccions was assessed. The 
immunoreactive GnRH peak stimulated release of LH (Fig. 19) in a chicken 
dispersed anterior pituitary cell bioassay. His 5 ,Trp7 ,Tyr8-GnRH has 
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Fig. 17. Chicken pituitary cell bioassay. Effect of alligator brain 
GnRH in HPLC fractions (system 1) and 10-7 M (maximal 
stimulation, M) on LH release from chicken pituitary cells. LH release 
is expressed as pg LH/ml of cell medium with basal release subtracted 
(open column). Columns represent the mean+ SEM (n = 3) of an assay for 
each HPLC fraction. Immunoreactive GnRH (antiserum 80/1) per HPLC 
fraction aliquot taken for the bioassay is expressed as ng GnRH/aliquot 
of HPLC fraction (dotted column). Elution positions of Gln8-GnRH (1), 
mammalian GnRH (2), Trp 7 ,Leu8-GnRH (3) and His 5 ,Trp7,Tyr8-GnRH (4) are 
indicated. 
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Fig. 18. Analytical HPLC of skink hrain GnRH (system 2, 241 pg, GnRH, 
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(1), mammalian GnRH (2), Trp 7,Leu8-GnRH (3) and Hiss,Trp7,Tyr8-GnRH (4) 
are indicated. 
62 
LR-releasing activity in this bioassay (Millar and King, 1984; Chou et 
al., 1985). The immunoreactive peak had only 396 pg of GnRH (measured 
by antiserum 80/1) and yet stimulated a substantial release of LH, 
indicating that this peak could be His 5 ,Trp7,Tyr8-GnRH, which 
cross-reacts only 5% with antiserum 80/1 (King and Millar, 1985). 
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Fig. 19. Chicken pituitary cell bioassay. Effect of skink brain GnRH in 
pooled HPLC fractions (system 2) and M (maximal 
stimulation, M) on LH release from dispersed chicken pituitary cells. LH 
release is expressed as µg LH release/ml of cell medium with basal 
release subtracted (open column). Columns represent the mean~ SEM (n = 
3) of an assay for each pool of HPLC fractions (in twos). Immunoreactive 
GnRH (antiserum 80/1) per HPLC fraction pool taken for the bioassay is 
expressed as ng GnRH/aliquot of HPLC fraction pool (dotted column), 
Elution positions of Gln 8-GnRH (1), mammalian GnRH (2), Trp 7 ,Leu 8-GnRH 
(3) and His 5 ,Trp7,Tyr8-GnRH (4) are indicated. 
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4.4 DISCUSSION 
These studies demonstrate structural diversity in reptilian GnRH. Two 
GnRHs, with identical chromatographic, immunological and hiological 
properties to Gln8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH, were present in 
alligator brain. Preliminary studies with GnRH antisera IJ-29 and R-42 
indicated that alligator hypothalamic GoRH differs from the mammalian 
GnRH in at least position 8 (Lance, 1985; Lance et al., 1985). Skink 
brain had only one detectable form of GnRH, with similar properties to 
His5,Trp7,Tyr8-GnRH. In the lizard (C. nigra) four immunoreactive GnRHs 
were present, two of which have identical chromatographic, immunological 
and biological properties to Trp 7 ,Leu8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH 
(Powell et al., 1985). One of the other two GnRH forms co-eluted with 
on reverse phase HPLC, but had different immunological 
properties (Powell!! al., 1985). 
The two GnRHs in alligator brain, Gln8-GnRH and H1s 5 ,Trp 7 ,Tyr8-GnRH, are 
also present in chicken hypothalamus (King and Millar, 1982a, 1982c; 
Miyamoto et al., 1983, 1984). Alligators are believed to be 
phylogenetically related to birds and possibly they have a common 
ancestor (Romer, 1970). The fact that alligator and bird GnRHs appear to 
be the same, is consistent with this theory of evolution. 
Skink brain had a GnRH form similar to His5,Trp7,Tyr8-GnRH, which was 
also present in C. nigra and in the alligator. This molecular form of 
GnRH is widespread among vertebrates and possibly represents an 
early-evolved and conserved GnRH form (Millar and King, 1986). This form 
of GnRH seems to occur in most reptiles. 
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5.0 DIVERSE MOLECULAR FORMS OF GnRH IN BRAIN TISSUE OF 
AN ELASMOBRANCH AND A TELEOST FISH 
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5.1 ABSTRACT 
Immunoreactive and biologically active gonadotropin-releasing hormones 
in dogfish(.!'.._. africanum) and teleost (C. julis) brain extracts were 
studied by HPLC, radioimmunoassay with region-specific GnRH antisera and 
by assessment of LH-releasing activity in a chicken dispersed anterior 
pituitary cell bioassay. In dogfish brain extract, seven GnRH molecular 
forms with LH-releasing activity were demonstrated. Three of these forms 
co-eluted with synthetic mammalian GnRH, His 5 ,Trp7 ,Tyr8-GnRH and 
Trp7,Leu8-GnRH on HPLC. The peaks coincident with Hls5,Trp7,Tyr8-GnRH 
and Trp 7 ,Leu8-GnRH had ictentical immunological and hiological properties 
to the synthetic peptides. However, the molecular form co-eluting with 
mammalian GnRH had different immunological and biological properties from 
mammalian GnRH and is thus a novel molecular variant of GnRH. The four 
remaining forms were also novel GnRHs or structurally unrelated peptides 
with LH-releasing activity. Immunoreactive GnRH occurred in dogfish 
systemic blood. In teleost brain extract, three biologically active GnRH 
forms with LH-releasing activity were present. The major peak of GnRH 
immunoreactivity co-eluted with Trp 7 ,Leu8-GnRH, and a second 
immunoreactive form co-eluted with His 5 ,Trp 7 ,Tyr8-GnRH. The third 
biologically active peak is a novel, early-eluting molecular variant of 
GnRH or a structurally unrelated peptide with LH-releasing activity. 
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5.2 INTRODUCTORY STATEMENT 
Three different classes of fish occur, the agnathans, osteichthyes and 
chondrichthyes. Numerous studies have been performed on GnRH structure 
of osteichthyes, and a GnRH in salmon (.2....:.._ keta) brain has been identified 
as Trp 7 ,Leu8-GnRH (Sherwood et al., 1983). A GnRH with similar 
properties to Trp 7,Leu8-GnRH occurs in most teleosts studied (Jackson and 
Pan, 1983; Sherwood et al., 1983; Breton et al., 1984; King and Millar, 
1985; Sherwood et al., 1984). Multiple forms of GnRH have been 
demonstrated in hake (~ capensis) pituitary gland, and in the brain of 
tilapia (T. sparrmanii), codfish (G. morhua morhua), milk fish (~ 
chanos), trout (S. gairdneri) and mullet (M. cephalus) brain (Barnett et 
------
al., 1982; Jackson and Pan, 1983; Sherwood et al., 1984; King and Millar 
1985). 
of which 
(Sherwood 
In lamprey(~ marinus) brain, two forms of GnRH are present, one 
has been characterized as 
et al., 1986). However, the structure of GnRH in 
chondrichthyes has not been thoroughly investigated. Immunoreactive GnRH 
has been detected in certain chondrichthyes (Jackson, 1980; King and 
Millar, 1980), whereas no detectable immunoreactive GnRH occurred in 
others (Deery, 1974; Nozaki and Kobayashi, 1979). On HPLC, S. acanthias 
brain GnRH eluted as two immunoreactive peaks, neither co-eluting with 
mammalian GnRH or Trp 7 ,Leu8-GnRH (Sherwood and Sower, 1985). 
\ 
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5.3 RESULTS 
Dogfish tissue extracts 
Quantitation of GnRH 
Immunoreactive GnRH content and concentration (antiserum 80/1) are given 
in Table V. GnRH concentration in the hypothalamus was higher than in 
extrahypothalamic brain; total content of GnRH was similar. The 
pituitary gland contained no detectable immunoreactive GnRH. 
Immunoreactive GnRH concentration in dogfish brain varied seasonally, 
being higher in dogfish collected in spring (October) than in those 
collected in autumn (March, April). Immunoreactive GnRH occurred in 
dogfish systemic hlood at a concentration equivalent to that reported in 
hypophysial portal blood of mammals (Clarke and Cummins, 1982). GnRH 
binding substances and peptidases, which could yield artificial GnRH 
immunoreactivity, were not present in serum or hypothalamic extracts. 
Chromatography and radioimmunoassay of dogfish brain extract 
Immunoreactive GnRH in Batch C (whole brain) eluted as a single broad 
peak (antiserum 80/1) on gel filtration (Fig. 20), later than mammalian 
GnRH, possibly due to other constituents of the extract causing 
adsorption. Batch B (whole brain) 1mmunoreactive GnRH eluted in a 
similar manner (data not shown). 
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C) (132 ng GnRH, antiserum 80/1). The void volume (Vo), salt elution 
volume (Vs) and elution position of mammalian GnRH are indicated. The 
hatched block indicates the fractions pooled for further analysis. 
71 
On semipreparative HPLC, the immunoreactive GnRH peak (Batch C) from gel 
filtration eluted as seven immunoreactive peaks (antiserum 80/1) (Fig. 
21). 
Immunoreactive peaks from tne above run were pooled together and 
chromatographed on analytical HPLC system 2. Five immunoreactive GnRH 
peaks (antiserum 80/1) were separated (Fig. 22A). Peaks II and III 
eluted in similar positions to mammalian GnRH and His 5 ,Trp 7 ,Tyr8-GnRH, 
respectively. Peak IV eluted in the region of Trp 7 ,Leu8-GnRH. Peak II, 
which eluted in the position of mammalian GnRH, had a relative 
immunoreactivity of 40% with antiserum 1076 compared with antiserum 80/1 
(Fig. 22B) (Table VI). Synthetic mammalian GnRH cross-reacts equally 
with these two antisera (Table VI); thus peak II is clearly not 
identifiable as mammalian GnRH. Peak III had a relative immunoreactivity 
of 0.9% with antiserum 1076 (relative to antiserum 80/1) (Fig. 22B) and 
13% with antiserum 802 (relative to Trp 7 ,Leu8-GnRH) (Table VI), which is 
similar to the cross-reaction of synthetic His 5 ,Trp 7 ,Tyr8-GnRH with these 
antisera (Table VI). Peak IV cross-reacted less than 0.5% with antiserum 
1076 relative to antiserum 80/1 and fully with antiserum 802 (Table VI), 
which is identical to the cross-reaction of synthetic Trp 7 ,Leu8-GnRH with 
these antisera (Table VI). Peaks I and V did not cross-react with 
antisera 1076 and 802 and therefore have the N-and C-termini in common 
with mammalian GnRH, but considerable structural differences from the 
known GnRHs in other regions of the molecule. Batch B immunoreactive 
GnRH eluted similarly on HPLC system 1 (data not shown). 
Fig. 21. 
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Chicken LH-releasing activity 
The five immunoreactive GnRH peaks (Batch C, HPLC system 2) (Fig. 22A) 
all stimulated chicken LH release (Fig. 23). Several additional 
bioactive peaks were identified which were not detected by 
radioimmunoassay. Peak II, which co-eluted with mammalian GnRH (0.37 ng, 
antiserum 80/1), released 0.2 µg of LH. This confirms that the peak is 
not mammalian GnRH, as a similar amount of mammalian GnRH (assayed hy 
antiserum 80/1) would not have LH-releasing activity. It appears, 
therefore, that this peak has substantial LH-releasing activity and is 
poorly immunoreactive. Peak III, co-eluting with His 5 ,Trp7 ,Tyr8-GnRH 
(2.9 ng, antiserum 80/1), stimulated LH release maximally as did 100 ng 
Gln8-GnRH. This further supports the identification of this peak as 
His 5 ,Trp 7 ,Tyr8-GnRH, 
His 5 ,Trp 7 ,Tyr8-GnRH 
since 
would 
a 
release 
similar amount of synthetic 
LH maximally. His 5 ,Trp7 ,Tyr8-GnRH 
cross-reacts only 5% with antiserum 80/1 (King and Millar, 1985) 
(relative to mass) and is 5 times more potent than Gln8-GnRH (Millar and 
et al., 1985). Peak IV, which co-eluted with King, 1984; Chou 
Trp 7 ,Leu8-GnRH (2.1 ng, antiserum 80/1), released a substantial amount of 
LH. The same amount of synthetic Tr.p7,Leu8-GnRH would release a similar 
amount of LH. Trp 7 ,Leu8-GnRH cross-reacts 30% with antiserum 80/1 (King 
and Millar, 1985). 
Trp7,Leu8-GnRH in the 
1984) 
is twice as potent as 
chicken pituitary cell hioassay (Millar and King, 
Seven LH-releasing peaks were also present in Batch B dogfish brains 
(data not shown). 
c. 
These peaks correspond to those demonstrated in Batch 
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Fig. 23. Chicken pituitary cell bioassay. Effect of dogfish brain GnRH 
in pooled HPLC fractions (Batch C, system 2) and 10-7 M Gln8-GnRH 
(maximal stimulation, M) on LH release from chicken anterior pituitary 
cells. LH release is expressed as µg LH/ml of cell medium with basal 
release subtracted (open column). Columns represent the mean+ SEM (n = 
3) of an assay for each pool of HPLC fractions (in twos). Immunoreactive 
GnRH (antiserum 80/1) per HPLC fraction pool taken for the bioassay is 
expressed ng GnRH/aliquot of HPLC fraction pool (dotted column). Elution 
positions of Gln8-GnRH (1), mammalian GnRH (2), Trp7,Leu 8-GnRH (3) and 
His 5 ,Trp 7 ,Tyr8-GnRH (4) are indicated. 
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Teleost brain extract 
Chromatography and radioimmunoassay of teleost brain extract 
The concentration of immunoreactive GnRH in teleost whole brain was 20.6 
pg GnRH/m~ dry wei~ht (Table 
immunoreactive GnRH peak (antiserum 
(Fi~. 24A). A smaller peak 
His5,Trp 7 ,Tyr8-GnRH (Fig. 24A). 
Chicken LH-releasing activity 
V). In HPLC system 
80/1) co-eluted with 
(antiserum 80/1) 
2, one major 
Trp 7 ,Leu8-GnRH 
co-eluted with 
Both immunoreactive peaks (antiserum 80/1) stimulated release of LH. 
(Fig. 24B). His5,Trp7,Tyr8-GnRH is twice as potent as Trp7,Leu 8-GnRH in 
the chicken anterior pituitary cell bioassay (Millar and King, 1984). 
However, if the two peaks were His 5 ,Trp7,Tyr8-GnRH and Trp 7 ,Leu8-GnRH 
respectively, they would be equipotent in this bioassay. A third 
bioactive GnRH, which had no GnRH immunoreactivity, eluted early on HPLC 
and appears to be a novel, hydrophilic form of GnRH or an unrelated 
peptide which releases LH. A large amount of LH was released in the late 
fractions. As the amount of LH released is above maximal release, it is 
thought to be due to lysing of the cells, 
acetonitrile in the HPLC fractions. 
because of residual 
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Fig. 24. Analytical HPLC (system 3, 2.98 ng GoRH, recovery was 74.4%, 
antiserum 80/1) and chicken pituitary cell bioassay of teleost brain 
GnRH. A. Fractions were assayed with antiserum 80/1. Elution positions 
of (1)' mammalian GnRH ( 2)' Trp 7 ,Leu8-GnRH (3) and 
His5,Trp7,Tyr8-GnRH (4) are indicated. B. Effect of teleost brain GnRH 
in pooled HPLC fractions and 10-7 M Gln8-GnRH (maximal stimulation, M) on 
LH release from dispersed chicken pituitary cells. LH release is 
expressed as ug LH release/ml of cell medium with basal release 
subtracted (open column). Columns represent the mean+ SEM (n = 3) of an 
assay for each pool of HPLC fraction (in twos). 
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DISCUSSION 
In dogfish brain, GnRH concentration was greater in the hypothalamus than 
in extrahypothalamic brain. There may be seasonal variations in GnRH 
concentration as brains of dogfish killed in spring contained more GnRH 
than those killed in autumn. Dogfish pituitary gland contained no 
detectable GnRH. In teleost fish, however, a number of 
immuoocytochemical and radioimmunoassay studies nave demonstrated the 
presence of GnRH in the pituitary gland (Goos and Murathanoglu, 1977; 
Nozaki and Kobayashi, 1979; Schreibman et al., 1979; Margolis-Kazan et 
al., 1981; Milnz et al., 1981; Goos et al., 1985; King and Millar, 1985). 
In teleosts the median eminence interdigitates with the pituitary gland 
(Ball, 1981) whereas in elasmobranch fish no vascular or nervous 
relationship exists between the median eminence and ventral lobe of the 
anterior pituitary, where gonadotropin is released (Dodd, 1975). GnRH 
immunoreactive material was not detected in the pituitary gland of the 
dogfish (T. scyllia) (Nozaki and Kobayashi, 1979). Immunoreactive GnRH 
in dogfish blood has previously been described (King and Millar, 1980), 
and its presence is confirmed in this study. Whether this indicates 
systemic activation of the pituitary gland via GnRH released into the 
general circulation is an intriguing possibility requiring further 
investigation. 
Seven peaks with LH-releasing activity were demonstrated in dogfish 
brain. Two of these peaks have been partially characterized, by elution 
position on HPLC, radioimmunoassay with region-specific GnRH antisera and 
assessment of LH-releasing activity, as His 5 ,Trp 7 ,Tyr8-GnRH and 
Trp 7 ,Leu8-GnRH. Although our findings strongly support this 
identification, it is possible that there are novel GnRH forms with 
similar properties. 
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Trp7,Leu8-GnRH appears to be present in all teleost fish studied (Jackson 
and Pan, 1983; Sherwood et al., 1983; Breton et al., 1984; Sherwood et 
al., 1984; King and Millar, 1985). His 5 ,Trp 7 ,Tyr8-GnRH is a widespread 
form and possibly represents an early-evolved and conserved GnRH. A 
third GnRH form in dogfish brain co-eluted with mammalian GnRH on HPLC, 
but cross-reacted differently with certain antisera and had bioactivity 
higher than appropriate for mammalian GnRH. In lamprey brain a GnRH form 
has been identified, which co-elutes with mammalian GnRH, but differs 
immunologically (Sherwood and Sower, 1985). The four other LB-releasing 
peptides in dogfish brain appear to be novel forms of GnRH or unrelated 
peptides with LR-releasing activity. As none of these forms 
cross-reacted with antiserum 1076, they are likely to have changes in the 
middle region of the GnRH peptide. 
A GnRH form which co-eluted with Trp 7 ,Leu8-GnRH was present in the 
teleost. This finding adds to other data showing that in all teleost 
species investigated a GnRH form identical to Trp 7 ,Leu8-GnRH occurs 
(Jackson and Pan, 1983; Sherwood et al., 1983; Breton et al., 1984; 
Sherwood et al., 1984; King and Millar, 1985). Of the two other 
LB-releasing factors present in this species, one form co-eluted with 
His 5 ,Trp7,Tyr8-GnRH. 
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6.0 CONCLUDING DISCUSSION 
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The purpose of this study was to gain insight into the possible evolution 
of the structure of vertebrate brain GnRH and its functions. Over the 
last few years it has been demonstrated that a number of different 
molecular forms of GnRH occur. Five different GnRH forms have been 
isolated from vertebrate brain, and additional novel forms, with 
different chromatographic, immunological and biological characteristics 
have been demonstrated. The five structurally characterized and 
naturally-occurring GnRHs have an effect on the pituitary-gonadal axis in 
the species/class from which they were isolated, and are thus involved 
with reproduction. 
In birds, GnRHs have been structurally characterized from the hypothalami 
of chickens only. · The data on ostrich hypothalamic GnRHs are thus of 
considerable interest. In ostrich hypothalamus two immunoreactive GnRHs 
with identical chromatographic, immunological and biological properties 
to Gln8-GnRH and Hiss,Trp7,Tyr8-GnRH were present. As these two forms 
are present in chicken hypothalamus, it would appear that GnRH structure 
in birds has been conserved. Four other factors which released LH from 
chicken dispersed anterior pituitary cells were also present in ostrich 
hypothalamic extracts. Only one of these forms cross-reacted with GnRH 
antisera. These factors might also be present in chicken hypothalamus. 
King and Millar (1982a, 1982c) used affinity with 
antiserum 1076 as an initial step in the purification 
chromatography 
of Gln8-GnRH, and 
as these factors have little or low immunoreactivity with antiserum 1076, 
they would not have been bound by antiserum 1076 coupled to the affinity 
column. Miyamoto et al. (1983, 1984) used a rat anterior pituitary cell 
bioassay to monitor GnRHs in chicken hypothalamus. However, the factors 
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found in ostrich hypothalamus are likely to release LH only from chicken 
pituitary cells, as the mammalian receptor has stringent binding 
requirements (Milton et al., 1983; Millar and King, 1984). 
It is not known which of the GnRH molecular forms described in ostrich 
hypothalamus has a physiological role in releasin~ LH and/or FSH. In the 
chicken, both Gln8-GnRH and His5,Trp 7 ,Tyr8-GnRH stimulated LH and FSH 
release from chicken anterior 
Millar and 
concentrations. 
King, 
The 
1984; 
two 
pituitary 
Chou et 
peptides 
cells 
al., 
may 
(King and Millar, 1983; 
1985) at physiological 
act synergistically or 
antagonistically through the same or different receptors. 
that the greater activity of His 5 ,Trp 7 ,Tyr8-GnRH in 
It is possible 
stimulating LH 
release reflects its role as the primary regulator of gonadotropin 
secretion. However, in view of the non-stringency of the chicken GnRH 
receptor, enhanced activity of this form might not imply that this form 
of GnRH is the (or a) endogenous regulator. Immunocytochemical analysis 
of the distribution of the two forms of GnRH in the chicken hypothalamus 
(with antisera specific for the two forms) and the demonstration which 
form(s) are in nerve endings abutting on the hypophysial portal vessels 
will help clarify this issue. In addition, the effects of administration 
of specific antisera in vivo on gonadotropin secretion should reveal 
whether one or both of the GnRHs serves the role of regulating 
reproduction. The GnRHs may also regulate pituitary hormones other than 
the gonadotropins, as GnRH has been shown to be a potent stimulator of 
growth hormone release in goldfish (T. Marchant an<l R. Peter, personal 
communication) • 
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In ostrich extrahypothalamic brain, the presence of both Gln 8-GnRH and 
His 5 ,Trp7,Tyr8-GnRH has been demonstrated, as in the hypothalamus (R.C. 
Powell, H. Jach, R.P. Millar and J.A. King, submitted). In 
extrahypothalamic brain regions, these GnRHs may serve as 
neurotransmitters or neuromodulators in neuronal pathways subserving 
reproductive behaviour. Other roles in the central nervous system are 
possible. Extrahyp3thalamic brain GnRH has been described in a number of 
vertebrates (see Introduction). As Gln8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH are 
both present in the hypothalamus and in extrahypothalamic brain, it is 
possible that they are in a common precursor molecule. 
Of the two reptilian species studied, alligator brain contained two GnRHs 
with identical properties to Gln8-GoRH and His 5 ,Trp 7 ,Tyr8-GnRH, whereas a 
single GnRH form with properties similar to His 5 ,Trp 7 ,Tyr8-GnRH was 
demonstrated in skink brain. In a previous study on lizard (C. nigra) 
brain, four immunoreac ti ve ,, GnRHs were de tee ted, two of which had 
identical properties to Trp 7 ,Leu8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH (Powell et 
al., 1985). It appears that His 5 ,Trp 7 ,Tyr8-GnRH is widespread in 
reptiles. In Podarcis s. sicula (a lizard) brain, however, 
His 5 ,Trp7,Tyr8-GnRH was not detected. A GnRH with identical properties 
to Trp 7 ,Leu8-GnRH was present, as well as two novel forms of GnRH (R.C. 
Powell, G. Ciarcia, V. Lance, R.P. Millar and J.A. King, submitted). The 
three species of lizard (C. ocellatus tili~ugu, P. s. sicula and C. 
nigra) therefore seem to be similar with regard to the nature of their 
GnRH molecular forms, as GnRH with identical properties to 
His 5 ,Trp 7 ,Tyr8-GnRH and/or Trp 7 ,Leu8-GnRH is present in all three, but 
not Gln8-GnRH as in the alligator. 
The two GnRHs in alligator brain, Gln8-GnRH and His 5 ,Trp 7 ,Tyr8-GnRH, are 
also present in chicken (King and Millar, 1982a, 1982c; Miyamoto et al., 
1983, 1984) and ostrich hypothalamus. It is believed that alligators, 
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which belong to the subclass Archosaura (order Crocodilia) are 
phylogenetically remote from the base of the reptilian family tree and 
more closely related to birds (Romer, 1970). They show numerous features 
found in birds and thus the fact that alligator and hird GnRHs are 
identical is consistent with this theory of evolution. The fact that 
Gln8-GnRH was not present in any of the other reptiles studied also 
supports the theory that alligators are more closely related to the birds 
than are other reptiles. 
In dogfish 
present. Two 
(P. africanum) 
were partially 
brain, seven LH-releasing factors 
characterized as Trp 7 ,Leu8-GnRH 
were 
and 
His5,Trp7,Tyr8-GnRH; the others appear to be novel GnRHs or structurally 
unrelated peptides with LR-releasing activity. In another dogfish (S. 
acanthias), two immunoreactive GnRHs were present (Sherwood and Sower, 
1985), one of which eluted similarly to His 5 ,Trp 7 ,Tyr8-GnRH on HPLC. The 
other form appears to be a novel GnRH molecular form. In the other fish 
species studied, the teleost (~ julis), a GoRH with identical properties 
to Trp 7 ,Leu8-GnRH was present. A second GnRH form co-eluted with 
His 5 ,Trp 7 ,Tyr8-GnRH. Trp 7 ,Leu8-GnRH appears to be present in all teleost 
fish investigated (Jackson and Pan, 1983; Sherwood~ al., 1983; Breton 
!!_ al., 1984; Sherwood et al., 1984; King and Millar, 1985). A GnRH in 
trout (S. gairdneri) brain (Sherwood and Sower, 1985) also eluted in the 
same position as His 5 ,Trp7,Tyr8-GnRH. Thus it seems that the dogfish (P. 
africanum) has similar GnRHs to those in teleost fish, whereas S. 
acanthias differs in lacking Trp 7 ,Leu8-GnRH. His 5 ,Trp 7 ,Tyr8-GnRH seems 
to be a very widespread form of GnRH. A GnRH with identical properties 
is present in chicken (Miyamoto et al. , 1984) and ostrich hypo thalamus, 
in alligator and lizard brain (Powell et al., 1985), in frog (X. laevis) 
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brain (King and Millar, 1986), and possibly also in trout and dogfish 
brain (Sherwood and Sower, 1985). Therefore, it may be an early-evolved 
and conserved form of GnRH. 
demonstrated in mammalian species. 
It has, however, not as yet been 
Interestingly, His 5 ,Trp 7 ,Tyr8-GnRH 
released 32% LH and 41% FSH compared with mammalian GnRH in rat pituitary 
cells (Miyamoto et al., 1984), which is far greater than the 
gonadotropin-releasing activity of the other GnRHs found in submammalian 
vertebrates. This could be an indication that this GnRH molecular form 
does occur in mammals, but has not been detected. 
Multiple forms of GnRH have been described previously in brain tissue of 
species of bird (King and Millar, 1982a, 1982c; Miyamoto et al., 1983, 
1984), reptile (Powell et al., 1985), amphibian (Branton et al., 1982; 
King and Millar, 1985), numerous species of teleost fish (Barnett~ al., 
1982; Jackson and Pan, 1983; Sherwood et al., 1983, 1984; King and 
Millar, 1985), and in an elasmobranch and cyclostome fish (Sherwood and 
Sower, 1985; Sherwood et al., 1986). In mammals, King and Millar (1981) 
reported two forms of GnRH in sheep pineal gland and hypothalamus. The 
structure of the second form has not been established. The function of 
the various forms of GoRH in these vertebrates has not been determined. 
It also remains to be discovered which form(s) regulates the release of 
gonadotropins endogenously. Some of the GnRHs described may occur in 
extrahypothalamic brain areas and may have neurotransmitter functions 
(Jones et al., 1984) or be involved with reproductive behaviour (Cheng, 
1977; Mauk et al., 1980; Dluzen et al., 1981; Dluzen and Ramirez, 1983). 
GnRHs in higher vertebrates (birds and mammals) seem to be more conserved 
87 
than those in lower vertebrates (reptiles and fish). 
In elasmobranch and cyclostome fish, there is no vascular or nervous 
connection between the median eminence and pars distalis (Dodd, 1975; 
Nozaki et al., 1984b). However, GnRH-like substances are present in 
dogfish and lamprey brain. Hagfish seem to have either no or very small 
amounts of GnRH (Crim et al., 1979a; Nozaki and Kooayashi, 1979; Jackson, 
1980; King and Millar, 1980; Sherwood and Sower, 1985). This may be due 
to the fact that most hagfish are continuous breeders, thus not requiring 
a GnRH. The hagfish can release eggs for many months after 
hypophysectomy (Matty et al., 1976; Gorbman, 1980). The GnRH may, 
however, differ vastly from the known forms, so that it is undetectable 
by antisera directed against the known GnRHs and inactive in bioassays in 
the higher vertebrates. 
Amongst invertebrates, analysis of earthworm (Lumbricus terres tris) 
extract by HPLC and radioimmunoassay revealed no immunoreactive GnRH (R. 
C. Powell, R.P. Millar and J.A. King, unpublished). Yeast 0<, -mating 
factor (a peptide involved with "gamete" formation in Saccharomyces 
cerevisiae) has six of thirteen amino acids in common with mammalian 
GnRH. Table VII indicates the homology of yeast ex. -mating factor with 
the other naturally-occurring GnRHs. Lamprey GnRH also has six amino 
acids homologous, whereas the others have less homology. 
In most of the vertebrate species, two or more GnRH molecular forms 
appear to be present in the same brain tissue, suggesting that gene 
duplication occurred during GnRH evolution. Lamprey GnRH is the GnRH 
form with the most nucleotide base changes with respect to the other 
GnRHs (Fig. 25), the next being chicken GnRH II. Chicken GnRH II 
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TABLE VII . HOMOLOGY OF THE KNOWN NATURALLY-OCCURRING GnRHs WITH 
YEASTC(.- MATING FACTOR 
Yeast ex. -ma ting 
factor 
Mammalian GnRH 
Chicken GnRH I 
Chicken GnRH II 
Salmon GnRH 
Lamprey GnRH 
1 2 3 4 5 6 7 8 9 10 11 12 13 
Trp.His.Trp.Leu.Gln.Leu.Lys.Pro.Gly.Gln.Pro.Met.Tyr 
1 2 3 4 5 6 7 8 9 10 
pGlu.His.Trp.Ser.Tyr.Gly.Leu.Arg.*Pro.Gly-NH 2 
pGlu.His.Trp.Ser.TYr.Gly.Leu.Gln. Pro. Gly-NH2 
pGlu.His.Trp.Ser.His.Gly.Trp.Tyr. Pro. Gly-NH 2 
pGlu.His.Trp.Ser.Tyr.Gly.Trp.Leu. Pro. Gly-NH2 
pGlu.His.Tyr.Ser.Leu.Glu.Trp.Lys. Pro. Gly-NH 2 
-----------------------------------
-----------------------------------
-----
Sequence homologies to yeastoc-mating factor are underlined. * Arg is 
considered homologous to Lys. 
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mGnRH 
cGnRH I 
lGnRH 
sGnRH 
Fig. 25. Minimum number of base changes required to convert 
Tyr3,Leu 5,G1u 6,Trp 7,Lys 8-GnRH (1 GnRH) into the other four known 
naturally-occurring GnRHs, and minimum number of base changes 
required to interconvert mammalian GnRH (m GnRH), Gln8-GnRH (c GnRH I), 
Trp 7,Leu8-GnRH (s GnRH) and His 5 ,Trp7,Tyr8-GnRH (c GnRH II). 
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(His5,Trp7,Tyr8-GnRH) seems to be the most widespead GnRH form amongst 
vertebrates and may have arisen early after gene duplication and remained 
conserv'ed. Trp 7 occurs in three of the known GnRHs, lamprey GnRH 
(Tyr3,Leu5,Glu6,Trp7,Lys8-GnRH), salmon GnRH (Trp 7 ,Leu8-GnRH) and chicken 
GnRH II (His5,Trp7,Tyr8-GnRH), whereas Leu 7 occurs in mammalian GnRH and 
chicken GnRH I (Gln8-GnRH). This may indicate how the GnRHs have 
evolved. It seems possible that lamprey, salmon and chicken GnRH II 
evolved first as they occur mainly in lower vertebrates. 
The GnRH molecule has, however, remained conserved in certain regions of 
the molecule. The length of the five known naturally-occurring GnRHs is 
constant. The two C-terminal and two N-terminal amino acids and Ser in 
position 4 have remained unchanged. These conserved residues may be the 
most important for activity. The N- and C-termini are thought to bind to 
the GnRH receptor, as only middle-directed antisera will recognise 
receptor-bound GnRH (Eidne et al., 1985). Serine is believed to be 
necessary for maintaining the GnRH conformation (Struthers et al., 1985). 
The mammalian-type GnRH seems to occur only in mammals and amphibians, 
and Gln8-GnRH in birds and higher reptiles. Trp 7 ,Leu8-GnRH is present in 
gnathostomes (chondrichthyes and osteichthyes fish), but not in 
cyclostomes. His 5 ,Trp 7 ,Tyr8-GnRH occurs in four of the five vertebrate 
classes (birds, reptiles, amphibians and gnathostomes); and may have a 
specific function which has been conserved. 
Tyr3 ,Leu 5 ,G1u6 ,Trp 7 ,Lys 8-GnRH has only recently been discovered in the 
lamprey and seems to be a more primitive GnRH form as it differs 
considerably from the other four forms. It may have changed during 400 
million years of separate evolution. A number of novel GnRHs have been 
demonstrated in different vertebrate species and elucidation of their 
structures will provide greater clarity in understanding the evolution of 
GnRH. 
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